{
  "timestamp": "2025-10-31T22:19:13.623Z",
  "url": "https://chat.formul8.ai",
  "totalQuestions": 438,
  "completed": 40,
  "passed": 11,
  "failed": 29,
  "averageScore": "42.88",
  "averageGrade": "F",
  "results": [
    {
      "questionNum": 1,
      "question": "Can you make me a compliant SOP for Cannabis Transport in New Jersey?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Standard Operating Procedure (SOP) – Cannabis Transport**  \n**State:** New Jersey  \n**Effective Date:** ___________  \n**Version:** 1.0  \n**Prepared By:** _______________________  \n**Approved By:** _______________________  \n\n---\n\n### 1. Purpose\nTo establish a consistent, secure, and **compliant** process for the transportation of licensed cannabis, cannabis products, and related materials between licensed cultivation, processing, testing, distribution, and retail facilities in New Jersey, in accordance with the **New Jersey Cannabis Regulatory Commission (CRC) Rules (N.J.A.C. 13:45‑1 et seq.)**, the **New Jersey Department of Health (NJDOH)‑approved “Transporter License”**, and applicable state‑wide security and record‑keeping requirements.\n\n---\n\n### 2. Scope\nThis SOP applies to **all employees, contractors, and third‑party vendors** who:\n\n* Hold a valid **Transporter License** issued by the CRC.  \n* Operate or provide vehicles, containers, or technology used for the movement of cannabis or cannabis‑derived products **within New Jersey**.  \n\nIt covers **in‑state** transport only; out‑of‑state movement is prohibited unless expressly authorized by the CRC.\n\n---\n\n### 3. Definitions\n| Term | Definition |\n|------|------------|\n| **Transporter** | Person or entity holding a CRC‑issued Transporter License. |\n| **Secure Container** | Tamper‑evident, sealed, and locked container meeting CRC specifications (e.g., NIST‑approved, opaque, and climate‑controlled when required). |\n| **Chain of Custody (CoC)** | Documented record of each individual who possesses the product from load to unload. |\n| **GPS Tracking** | Real‑time location monitoring system approved by the CRC and installed on every transport vehicle. |\n| **Incident Report** | Form used to document any deviation, loss, theft, or accident involving cannabis during transport. |\n\n---\n\n### 4. Responsibilities  \n\n| Role | Primary Duties |\n|------|----------------|\n| **Transport Manager** | Approves routes, schedules, driver assignments; ensures vehicle compliance; maintains CoC logs. |\n| **Licensed Driver** | Holds a valid **NJ Driver’s License** and **Transporter License**, completes pre‑trip checks, secures load, maintains GPS, and completes post‑trip documentation. |\n| **Security Officer** | Conducts risk assessments, verifies security equipment (cameras, alarms), reviews incident reports. |\n| **Compliance Officer** | Audits SOP adherence, updates SOP with regulatory changes, retains records for 5 years. |\n| **Dispatch** | Provides approved route, communicates any changes, monitors GPS alerts. |\n\n---\n\n### 5. Prerequisite Requirements  \n\n1. **Licensing** – All drivers and the transporting entity must have a current CRC Transporter License.  \n2. **Vehicle** – Must be a **dedicated, marked** vehicle meeting CRC standards (e.g., no passenger seating, opaque windows, lockable doors).  \n3. **GPS & Monitoring** – Real‑time GPS device must be active and data retained for at least **30 days**.  \n4. **Secure Containers** – Must be **tamper‑evident**, **opaque**, and **locked**; containers are to be inspected for integrity before each load.  \n5. **Insurance** – Minimum $1 million liability coverage for cannabis transport, as required by CRC.  \n6. **Background Checks** – All drivers must pass a **state‑wide criminal background check** and a **fingerprint check** within the past 5 years.  \n\n---\n\n### 6. Procedure  \n\n#### 6.1 Pre‑Transport  \n\n| Step | Action | Owner |\n|------|--------|-------|\n| 6.1.1 | Verify Transporter License is active (expiration > 30 days). | Compliance Officer |\n| 6.1.2 | Conduct a **risk‑based route analysis** (traffic, construction, law‑enforcement presence). Approve the safest route. | Transport Manager |\n| 6.1.3 | Ensure vehicle inspection checklist is completed (tires\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1132 (132?1000) | Cost: $0.000000*",
      "duration": 12587,
      "grade": "F",
      "score": 40,
      "grading": {
        "accuracy": 8,
        "completeness": 7,
        "relevance": 12,
        "clarity_structure": 9,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear SOP structure with roles, responsibilities, and basic procedures",
        "Mentions core controls like GPS tracking, tamper-evident containers, and chain-of-custody",
        "Includes incident reporting and pre-transport checks concepts"
      ],
      "weaknesses": [
        "Incorrect citation of governing rules (uses N.J.A.C. 13:45 and NJDOH instead of NJ CRC N.J.A.C. 17:30)",
        "Mischaracterizes licensing (refers to a generic “Transporter License” rather than NJ CRC license classes such as Class 4 Distributor and Class 6 Delivery)",
        "Vehicle requirements likely incorrect (e.g., “dedicated, marked” vehicles; NJ typically requires unmarked vehicles and concealed cargo)",
        "Includes several unsupported specifics (insurance minimums, background check timelines, GPS retention) with no CRC basis",
        "Fails to outline key CRC-required elements like manifests, seed-to-sale (Metrc) details, personnel requirements, no extra stops, two-person team, prohibited items (e.g., firearms), and record retention",
        "Does not cover all relevant license classes (cultivators, manufacturers, wholesalers, distributors, retailers, delivery) or their transport permissions",
        "Procedure is truncated and incomplete"
      ],
      "feedback": "Well-structured but not compliant with New Jersey CRC rules. Replace NJDOH/13:45 references with N.J.A.C. 17:30 and align with CRC-defined license classes (e.g., Class 4 Distributor, Class 6 Delivery). Correct vehicle requirements (unmarked, secured cargo), and add CRC-required elements: Metrc manifests, route planning with no unauthorized stops, two-person crew, prohibited items (no firearms), security and communication protocols, incident reporting timelines, and record retention per CRC. Provide accurate, cited requirements (not assumptions) and complete the procedure end-to-end. A concise summary of key CRC requirements was expected.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "new jersey",
        "epa",
        "commission",
        "crc",
        "metrc",
        "sop",
        "procedure",
        "standard",
        "operating"
      ],
      "expectedAnswer": "I need to create a concise summary for a compliant SOP on cannabis transport in New Jersey. The summary should include main conclusions, key requirements, and critical regulatory details from the New Jersey Cannabis Regulatory Commission (CRC) rules, specifically N.J.A.C. 17:30. It’s important to outline what a compliant SOP must cover per NJ CRC regulations, including details about licensed Cannabis Business classes: Cultivators, Manufacturers, Wholesalers, Distributors, Retailers, Delivery s"
    },
    {
      "questionNum": 2,
      "question": "Can you make me a compliant SOP for pre-roll production in New York?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a **template‑style Standard Operating Procedure (SOP)** that you can adapt for a pre‑roll production line in New York State.  It is written to align with the 2024 New York Cannabis Law, the NY Office of Cannabis Management (OCM) regulations, and the Good Manufacturing Practices (GMP) requirements that the OCM has incorporated for adult‑use and medical cannabis operations.\n\n> **Important:**  This SOP is a starting point only.  Before implementation you must have it reviewed by your compliance officer, legal counsel, and the OCM (or a licensed consultant) to confirm that every clause meets the most current state‑specific rules, local ordinances, and any licensing conditions that apply to your facility.\n\n---\n\n## 1.  Document Control  \n\n| Item | Description |\n|------|-------------|\n| **SOP Title** | Pre‑Roll Production – NY State |\n| **SOP Number** | PR‑001 |\n| **Version** | 1.0 |\n| **Effective Date** | [Insert Date] |\n| **Review Date** | [Insert Date – 12 months from effective] |\n| **Approved By** | [Name, Title – e.g., Director of Operations] |\n| **Prepared By** | [Name, Title – e.g., QA Manager] |\n| **Distribution** | All production, QA/QC, and compliance staff (electronic copy on secured server) |\n| **Revision History** | See attached log |\n\n---\n\n## 2.  Purpose  \n\nTo define a repeatable, documented, and **regulatory‑compliant** process for receiving, handling, manufacturing, testing, packaging, labeling, and storing **pre‑rolled cannabis products** at the [Facility Name] location in New York State.\n\n---\n\n## 3.  Scope  \n\n- Applies to **all pre‑roll batches** produced at the facility, including both **medical‑use** and **adult‑use** product lines.  \n- Covers activities from **raw material receipt** through **final product release** and **distribution**.  \n- Excludes:  (a) research‑only activities, (b) extraction of raw flower (covered by separate SOPs).\n\n---\n\n## 4.  Definitions  \n\n| Term | Definition |\n|------|------------|\n| **Batch** | A quantity of product produced under a single manufacturing order and identified by a unique Batch/Lot ID. |\n| **QC** | Quality Control – laboratory testing performed on incoming material, in‑process, and finished product. |\n| **QA** | Quality Assurance – oversight function ensuring SOP adherence and regulatory compliance. |\n| **COA** | Certificate of Analysis – document issued by an OCM‑certified laboratory confirming product specifications. |\n| **OCM** | Office of Cannabis Management – NY State agency that regulates cannabis licensing, testing, labeling, and tracking. |\n| **Track‑and‑Trace (T&T)** | State‑mandated system (METRC‑compatible) that records every movement of cannabis from seed to sale. |\n| **THC‑A** | Total Δ⁹‑tetrahydrocannabinol (including acid form) as expressed on the COA. |\n\n---\n\n## 5.  Responsibilities  \n\n| Role | Primary Responsibilities |\n|------|---------------------------|\n| **Plant Manager** | Overall compliance; authorizes batch starts and releases. |\n| **Production Supervisor** | Executes SOP steps; ensures staff training; records deviations. |\n| **QC Analyst** | Performs required testing (potency, microbial, residual solvents, pesticide). |\n| **QA Coordinator** | Reviews all batch records, verifies COAs, signs off release. |\n| **Compliance Officer** | Monitors regulatory updates; maintains T&T entries; conducts internal audits. |\n| **Safety Officer** | Enforces\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1167 (167?1000) | Cost: $0.000000*",
      "duration": 4180,
      "grade": "F",
      "score": 54,
      "grading": {
        "accuracy": 16,
        "completeness": 9,
        "relevance": 16,
        "clarity_structure": 9,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Uses a structured SOP format with clear sections (document control, purpose, scope, definitions, responsibilities).",
        "References the NY Office of Cannabis Management and frames the SOP around compliance.",
        "Provides a practical template starting point tailored to pre-roll production."
      ],
      "weaknesses": [
        "Contains a material inaccuracy: states the track-and-trace system is METRC-compatible; New York uses the OCM-selected Cannabis Product Tracking System (BioTrack).",
        "The SOP is incomplete and cuts off mid-section, omitting critical operational and compliance steps.",
        "Lacks New York–specific regulatory citations and requirements (e.g., applicable 9 NYCRR parts, Cannabis Control Board/OCM roles).",
        "Does not address core compliance areas for pre-rolls: sanitation and environmental controls, personnel training, allergen/control of foreign material, batch size/lotting, weighing reconciliation, machine calibration and maintenance, sampling plans, hold-and-release with COA verification, packaging/labeling specifics (warnings, universal symbol, CR/TP packaging), waste and destruction, recalls/complaints, adverse event reporting, security, and recordkeeping.",
        "Includes irrelevant meta text at the end, reducing professionalism and clarity."
      ],
      "feedback": "The answer is on-topic and well-structured as a template, but it is incomplete and contains a key inaccuracy about New York’s track-and-trace system (NY uses the OCM-selected Cannabis Product Tracking System, commonly implemented via BioTrack, not METRC). Expand the SOP to include NY-specific regulatory references and required procedures: sanitation/cleaning validation, personnel training and qualifications, equipment calibration and maintenance, material control and reconciliations, in-process controls (grind size, moisture, weight tolerances), quality sampling and testing with COA review, packaging and labeling compliant with NY OCM rules (warnings, universal symbol, CR/TP packaging), inventory control and track-and-trace entries, waste handling and destruction, deviations/CAPA, recall and complaints, record retention, and security. Remove extraneous meta text and complete the unfinished sections to deliver a fully compliant, actionable SOP.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "mandatory",
        "must",
        "state",
        "new york",
        "osha",
        "epa",
        "metrc",
        "sop",
        "procedure",
        "standard",
        "operating"
      ],
      "expectedAnswer": "**Clarifying SOP Requirements** I need to summarize the expected answer for the user’s request about an SOP for pre-roll production in New York. This includes key requirements, regulatory details, and NY-specific info like the role of the Cannabis Control Board. I have to consider manufacturing regulations, sanitation, personnel training, and the track-and-trace system. Wait—did New York choose BioTrack for tracking? I should clarify that the Office of Cannabis Management selected the Cannabis Product Tracking System. Accuracy is key here, so I’ll double-check!"
    },
    {
      "questionNum": 3,
      "question": "Can you make me a product recall SOP?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Product Recall – Standard Operating Procedure (SOP)**  \n*Version 1.0 – [Date]*  \n*Applicable to: All cannabis‑derived products (edibles, concentrates, topicals, etc.) manufactured, packaged, or distributed by **[Your Company]***  \n\n---\n\n## 1. Purpose\nTo provide a clear, repeatable process for identifying, communicating, retrieving, and disposing of any product that may pose a health, safety, or regulatory risk, thereby protecting consumers, preserving brand integrity, and complying with state/federal regulations.\n\n## 2. Scope\n- All product lines, packaging formats, and distribution channels (retail, wholesale, online).  \n- Applies to recalls initiated by **[Your Company]** (voluntary) or mandated by a regulator.  \n\n## 3. Definitions\n| Term | Meaning |\n|------|---------|\n| **Recall** | Removal of a product from the market or consumer possession because of a defect or non‑compliance. |\n| **Recall Class** | **Class I** – severe health hazard; **Class II** – temporary or reversible health hazard; **Class III** – unlikely to cause adverse health effects. |\n| **Recall Coordinator (RC)** | Senior staff (usually QA Manager) responsible for overall recall execution. |\n| **Recall Team** | Cross‑functional group (QA, Production, Legal, Compliance, PR, Distribution, Finance). |\nAffected Lot** | Specific batch/lot numbers, production dates, or SKU(s) identified as problematic. |\n\n## 4. Responsibilities\n| Role | Primary Duties |\n|------|----------------|\n| **Recall Coordinator (RC)** | Trigger recall, lead team, maintain master log, liaise with regulators & external parties. |\n| **Quality Assurance (QA)** | Verify defect, conduct root‑cause analysis, ensure corrective actions. |\n| **Production/Packaging** | Halt manufacturing, isolate affected inventory, assist with retrieval. |\n| **Compliance/Legal** | File required regulatory notifications, maintain documentation, advise on liability. |\n| **Public Relations (PR)** | Draft consumer & media statements, manage social‑media response. |\n| **Distribution/Logistics** | Pull product from warehouses/retail, arrange transport for returned items. |\n| **Finance** | Track recall costs, issue refunds/credit as needed. |\n\n## 5. Recall Triggers\n- Consumer complaint with credible evidence of harm.  \n- Internal QC failure (e.g., potency out‑of‑spec, microbial contamination, pesticide residue).  \n- External lab test or regulator notice indicating non‑compliance.  \n- Packaging/labeling error that could cause misuse or misidentification.  \n\n## 6. Recall Process – Step‑by‑Step\n\n| Step | Action | Owner | Timeline |\n|------|--------|-------|----------|\n| **1. Detection & Initial Assessment** | Document issue, gather lot numbers, severity, potential impact. | QA / Production | ≤ 4 h of discovery |\n| **2. Decision to Recall** | RC convenes **Recall Decision Meeting** (RC, QA, Legal, Compliance). Determine recall class & scope. | RC | ≤ 8 h |\n| **3. Regulatory Notification** | Submit **Recall Notification Form** to state cannabis board, FDA (if applicable), and any other jurisdictional agency. Include: product description, lot numbers, reason, class, corrective actions. | Compliance/Legal | Within 24 h of decision |\n| **4. Internal Notification** | Activate Recall Team via pre‑approved channel (e.g., Slack/Teams “Recall‑Alert”). Distribute **Recall Action Sheet** with tasks, deadlines, contact list. | RC | Immediately after decision |\n| **5. Consumer & Retailer Communication** | Deploy **Recall Press Release** (PR), update website, email retailers, post on social media, and send **Recall Notice** to consumers (mail/email). Include: product name, lot, risk, instructions (return, destroy, refund).\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1160 (160?1000) | Cost: $0.000000*",
      "duration": 7277,
      "grade": "F",
      "score": 44,
      "grading": {
        "accuracy": 14,
        "completeness": 6,
        "relevance": 12,
        "clarity_structure": 7,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Provides a structured SOP framework with roles, triggers, and step-by-step actions",
        "Includes actionable elements like timelines, team responsibilities, and communication steps",
        "Covers common recall classes and operational controls (isolation, retrieval, PR coordination)"
      ],
      "weaknesses": [
        "Not tailored to New York cannabis regulations; no reference to OCM/CCB",
        "Missing citations to 9 NYCRR Part 131 (adult-use) and 10 NYCRR Part 1004 (medical)",
        "Omits explicit 24-hour notification to OCM and adverse event reporting requirements",
        "Mentions FDA involvement, which is generally not applicable for state-regulated cannabis recalls",
        "Does not specify required recordkeeping/retention, effectiveness checks, mock recall frequency, or disposition documentation per NY rules",
        "Content is truncated and contains an unrelated artifact line, reducing clarity and completeness"
      ],
      "feedback": "The SOP is a solid generic template but fails to meet New York-specific compliance needs. Add OCM/CCB oversight, cite 9 NYCRR Part 131 and 10 NYCRR Part 1004, include 24-hour notification to OCM for recalls/adverse events, define recordkeeping/retention, effectiveness checks, mock recall cadence, product disposition, and retailer/consumer notification content per NY guidance. Remove FDA references and complete the procedure end-to-end with NY-specific forms, contacts, and timelines.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "required",
        "must",
        "state",
        "fda",
        "epa",
        "agency",
        "board",
        "sop",
        "procedure",
        "standard",
        "operating",
        "documentation"
      ],
      "expectedAnswer": "**Summarizing recall SOP requirements** I need to provide a concise summary of creating a product recall SOP, specifically for New York cannabis regulations. It should include compliance with the Office of Cannabis Management (OCM) and Cannabis Control Board (CCB), referencing 9 NYCRR Part 131 for adult-use and 10 NYCRR Part 1004 for medical cannabis. The SOP must outline that licensees must have a recall plan, maintain records, and notify the OCM within 24 hours regarding any product recalls or adverse events.**Summarizing product recall SOP requirements** I need to create a concise summary for a Standard Operating Procedure (SOP) regarding product recalls, specifically relating to New York's cannabis regulations. The SOP must comply with rules from the Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB), covering both adult-use and medical cannabis. For adult-use, it must reference 9 NYCRR Part 131, while medical cannabis should align with former DOH regulations. I believe it should include plan requirements, record maintenance, and timely notifications to the OCM."
    },
    {
      "questionNum": 4,
      "question": "What are the requirements for testing regular pre-rolls when I bought the raw material from a cultivator that already tested it?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Testing Requirements for Finished Pre‑Rolls When the Flower Is Already COA‑Verified**\n\nBelow is a practical, state‑agnostic checklist that you can adapt to the specific regulations of the state where the product will be sold. Most jurisdictions (CA, CO, WA, MA, MI, OR, etc.) follow the same basic logic:\n\n| **What the regulator looks for** | **Why it matters for a pre‑roll** | **Typical requirement** | **How the existing flower COA helps (and its limits)** |\n|-----------------------------------|-----------------------------------|--------------------------|--------------------------------------------------------|\n| **Potency (THC, Δ⁹‑THC‑acid, CBD, CBC, CBG, etc.)** | Determines dosing, labeling, and consumer safety. | One test per batch of finished product (usually a 30 g or 1 kg lot). | The flower COA can be used to *prove* the starting material’s potency, but you must still test the final pre‑roll to confirm that the roll‑up process has not altered the cannabinoid profile (e.g., loss of volatile terpenes, oxidation). |\n| **Pesticides & Residual Solvents** | Prevents consumer exposure to harmful chemicals. | Full panel (often > 500 pesticide residues) + any solvent residues if extraction was used. | If the flower COA includes a comprehensive pesticide panel and the batch is still within the COA’s “age‑of‑sample” window (typically ≤ 30 days from collection), you may rely on it **only** for the raw flower. The finished pre‑roll must be re‑tested because: <br>• Contamination can be introduced during handling, trimming, or storage (e.g., dust, cross‑contamination). <br>• Some states require a “final product” pesticide test regardless of raw‑material data. |\n| **Microbiology (total aerobic count, yeasts & molds, E. coli, Salmonella, etc.)** | Prevents food‑borne illness. | One test per finished batch; some states also require a test on the raw flower. | Raw‑flower COA may cover total aerobic count and mold, but the finished pre‑roll must be tested because the rolling process can introduce moisture or spores (e.g., from the rolling paper, handling equipment). |\n| **Heavy Metals (Pb, As, Cd, Hg, etc.)** | Chronic toxicity risk. | One test per finished batch. | Same logic as pesticides – you can reference the raw‑flower result, but a final‑product test is required in most states. |\n| **Mycotoxins (aflatoxins, ochratoxin A, etc.)** | Specific to cannabis because of fungal growth. | Required if the state’s regulations list them; many require a final‑product test. | Raw‑flower COA may include mycotoxin data, but the finished product must be re‑tested because rolling can change moisture content and promote fungal growth. |\n| **Moisture / Water Activity (a_w)** | Affects shelf‑life, mold risk, and weight‑based dosing. | Usually a “final‑product” moisture test (≤ 15 % for flower, ≤ 10 % for pre‑rolls). | The raw‑flower moisture can be a baseline, but the finished pre‑roll must be measured because paper, filters, and handling add water. |\n| **Foreign Matter / Physical Defects** | Ensures product integrity. | Visual inspection + optional lab verification (e.g., ash, ash‑free). | Not covered by a raw‑flower COA – must be performed on the finished pre‑rolls. |\n| **Label Accuracy (potency, net weight, batch\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1218 (218?1000) | Cost: $0.000000*",
      "duration": 7327,
      "grade": "F",
      "score": 45,
      "grading": {
        "accuracy": 15,
        "completeness": 7,
        "relevance": 11,
        "clarity_structure": 7,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Provides a structured overview of common cannabis testing panels",
        "Highlights risks introduced during rolling that can necessitate final product testing",
        "Offers generally actionable categories (potency, pesticides, microbials, metals, moisture)"
      ],
      "weaknesses": [
        "Not tailored to New York regulations as requested; omits NY OCM-specific rules",
        "Misses key nuance that non-infused pre-rolls from a single compliant lot may rely on existing testing under NY rules",
        "Contains questionable specifics (e.g., “>500 pesticide residues,” fixed moisture limits for pre-rolls) that are not universally accurate",
        "Does not address NY lotting, sampling, mechanical processing exemptions, or chain-of-custody/COA reuse conditions",
        "Answer is truncated and includes irrelevant meta text, reducing clarity and professionalism"
      ],
      "feedback": "The response offers a generic checklist of testing considerations but fails to address New York’s specific requirements and exemptions for non-infused pre-rolls made from already-tested flower. For a strong answer, focus on NY OCM rules: when existing flower COAs suffice (single compliant lot, only mechanical processing, no additives), when final product testing is still required (blended lots, additives, reconstitution), lot and sampling requirements, and documentation/chain-of-custody. Remove generic or inaccurate claims and provide clear, NY-specific, actionable steps.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "board",
        "standard",
        "documentation",
        "document",
        "record",
        "log",
        "testing",
        "test",
        "coa",
        "certificate"
      ],
      "expectedAnswer": "**Summarizing NY pre-roll testing requirements** I need to summarize the requirements for testing pre-rolls when the raw material was already tested by the cultivator. In New York, all final cannabis products must be tested by an independent lab before they can be sold. There are specific rules related to lots, sampling, and some exemptions for mechanical processing. It seems that for non-infused pre-rolls made from a compliant batch, existing compliance testing can suffice if the product is homogeneous with no additives.**Outlining NY testing regulations** I need to summarize the requirements for testing regular pre-rolls when the raw material was already tested by a cultivator in New York. I'll focus on NY regulations related to cannabis product testing. According to NY OCM rules, all final products must be tested by an independent lab before retail sale. There are specific rules for lots, sampling, and some exemptions for non-infused pre-rolls from a single lot that already have compliance testing. I'll clarify these points."
    },
    {
      "questionNum": 5,
      "question": "Can I make an infused pre-roll without retesting it if I am using already tested flower and concentrate?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most jurisdictions you **must** retest the finished pre‑roll (or at least perform a limited verification) before it can be sold, even if the flower and concentrate were already tested. The act of combining, processing, and packaging creates a new product with its own potency, terpene, and contaminant profile.\n\n---\n\n## Why a new test is required\n\n| Reason | What changes when you make an infused pre‑roll |\n|--------|-----------------------------------------------|\n| **Potency redistribution** | The THC/CBD (and minor cannabinoids) in the concentrate are diluted into the flower matrix. The final % THC/CBD per gram of the pre‑roll will differ from the original flower or concentrate values. |\n| **Terpene profile** | Terpenes can evaporate, oxidize, or interact during heating/infusion, altering aroma, flavor, and even pharmacology. |\n| **Contaminants** | Pesticides, heavy metals, residual solvents, or microbial load can concentrate or disperse differently when you blend a concentrate with flower. |\n| **Homogeneity** | Even if you mix thoroughly, there is inherent batch‑to‑batch variability that must be documented. |\n| **Regulatory definition** | Most state/ provincial cannabis statutes define a “product” as the final packaged form. Any change in composition (e.g., adding a concentrate) creates a new product that must meet the testing requirements for that product category (e.g., “infused pre‑roll”). |\n| **Labeling compliance** | Accurate THC/CBD per serving, warning statements, and batch numbers all rely on lab‑verified data. |\n\n---\n\n## Typical Regulatory Requirements (U.S. example)\n\n| Jurisdiction | Requirement for a “new” product |\n|--------------|---------------------------------|\n| **California (B&C)** | Must submit a full batch test (potency, pesticides, residual solvents, microbial) for any product that has a different formulation from the source material. |\n| **Colorado** | Any product that is “infused” (e.g., concentrate added to flower) requires a new potency test and a pesticide test for the finished batch. |\n| **Ontario (Canada)** | A new “infused product” must be tested for cannabinoids, terpenes, pesticides, heavy metals, residual solvents, and microbial load. |\n| **European Union (if applicable)** | Requires a Certificate of Analysis for each finished product, regardless of source material testing. |\n\n*If you are outside these regions, check your local cannabis board/health authority – the principle is the same.*\n\n---\n\n## Practical Options If Full Lab Testing Is a Bottleneck\n\n1. **Limited “Verification” Testing**  \n   - Submit a **representative sub‑sample** of the finished pre‑roll for potency only.  \n   - Many labs offer a rapid “potency‑only” service (often 48‑72 h) that costs less than a full panel.\n\n2. **In‑house Screening**  \n   - Use a calibrated **HPLC or GC‑MS handheld unit** (or a validated spectroscopic device) to get a quick potency read‑out.  \n   - This can be used for **internal QC** but usually cannot replace a formal COA for regulatory compliance.\n\n3. **Batch‑size control**  \n   - Keep the batch size small (e.g., ≤ 5 g of finished pre‑roll) and perform a **full test on every batch**.  \n   - This reduces the risk of a large‑scale recall if the batch deviates.\n\n4. **Standardized infusion protocol**  \n   - Document the exact weight of flower, weight of concentrate, mixing method, and temperature/time parameters.  \n   - Consistency in the process reduces variability, making it easier to predict potency from the source data (though you still need a verification test).\n\n---\n\n## Quick “Do‑It‑Yourself” Potency Estimate (for internal planning)\n\nIf you want to **estimate** the THC% of the final pre‑roll before sending it to a lab:\n\n1. **Gather source data**  \n   - Flower: *THC_f* % (e.g., 20 %) and weight *W_f* (g)  \n   - Concentrate: *THC_c* % (e.g., 80 %) and weight *W_c* (g)\n\n2. **Calculate total THC mass**  \n   \\[\n   \\text{THC}_{\\text{total}} = (THC_f \\times W_f) + (TH\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1181 (181?1000) | Cost: $0.000000*",
      "duration": 13716,
      "grade": "F",
      "score": 50,
      "grading": {
        "accuracy": 16,
        "completeness": 8,
        "relevance": 12,
        "clarity_structure": 8,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Correct general principle that finished infused pre-rolls typically require retesting",
        "Provides rationale for retesting (potency redistribution, contaminants, homogeneity, labeling)",
        "Offers some practical process and QC suggestions"
      ],
      "weaknesses": [
        "Does not address New York-specific regulations or 9 NYCRR Part 130 as required",
        "Misses classification of infused pre-rolls as manufactured products under NY OCM and the resulting testing implications",
        "Lacks specifics on NY-required analytes (e.g., potency, heavy metals, residual solvents for hydrocarbon extracts, homogeneity) and labeling elements (e.g., total THC per serving/pack)",
        "Includes potentially inaccurate or oversimplified jurisdictional examples (e.g., Canada/terpene requirements, Colorado panel details)",
        "Answer is partially truncated and contains irrelevant internal note, hurting clarity"
      ],
      "feedback": "Your core message—that infused pre-rolls generally require final product testing—is directionally correct and useful, but the question calls for a concise New York–specific summary. Cite NY OCM rules (9 NYCRR Part 130), classify infused pre-rolls as manufactured products requiring final batch testing, and spell out the applicable NY analyte panels (potency, contaminants, residual solvents where applicable, homogeneity), along with labeling elements (total THC per serving/pack). Remove unrelated jurisdictional examples, fix the truncation, and provide concrete NY compliance steps.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "epa",
        "standard",
        "testing",
        "test",
        "coa"
      ],
      "expectedAnswer": "**Summarizing New York regulations** I need to create a concise summary about New York regulations on retesting infused pre-rolls when using previously tested flower and concentrates. It seems that most states generally require finished product testing, even if the inputs were already tested. The New York Office of Cannabis Management has specific rules for this, including guidelines for adult-use laboratories under 9 NYCRR Part 130. For infused pre-rolls, if they’re classified as “manufactured products,” additional testing may be required, but non-infused pre-rolls might not need full testing if there’s no further processing.**Clarifying infused product testing** When infused with concentrates like kief or hash oil, the product is classified as a \"cannabis product.\" This means it needs potency and contaminant testing for the final form. Testing should cover aspects such as homogeneity, heavy metals, and residual solvents, especially if hydrocarbon extracts are involved. Additionally, total THC per serving or pack and net weight will also require attention. There could be some allowances for compositing during this testing process, but I need to confirm that detail."
    },
    {
      "questionNum": 6,
      "question": "Do I have to show harvest date or production date on infused products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most U.S. states and Canadian provinces that regulate infused cannabis products, you are required to list a **production (manufacturing) date** (or a “manufacture/packaging” date) on the label, **not** the harvest date. A few jurisdictions also ask for a “lot/traceability” number that can be linked back to the harvest batch, but the harvest date itself is rarely a mandatory label field.\n\n---\n\n## 1. What the major regulators say\n\n| Jurisdiction | Required Date on Label | How it’s phrased | Typical format |\n|--------------|------------------------|-----------------|----------------|\n| **California (BPC) – Edibles, tinctures, topicals** | **Manufacture/Packaging Date** (or “Production Date”) | Must be “the date the product was manufactured, packaged, or filled.” | MM/DD/YYYY |\n| **Colorado (CRA) – Edibles & concentrates** | **Production/Manufacture Date** | “The date the product was manufactured, packaged or prepared.” | MM/DD/YY |\n| **Washington (LRI) – Edibles & concentrates** | **Manufacture/Packaging Date** | Same as above; must be “date of production.” | MM/DD/YYYY |\n| **Oregon (OSHA/OTC) – Edibles, tinctures** | **Production Date** | Must appear as “Production Date” or “Date of Manufacture.” | YYYY‑MM‑DD |\n| **Michigan (MCL) – Edibles** | **Manufacture Date** | Required on the label; harvest date is optional only for traceability records. | MM/DD/YYYY |\n| **Canada (Health Canada) – Cannabis extracts & edibles** | **Production Date** (or “Manufacture Date”) | Must be shown as “Date of Production” and paired with an expiry date. | YYYY‑MM‑DD |\n| **Other states** (e.g., Nevada, New York, Illinois) | Generally **Production/Manufacture Date** is required; harvest date is not a label requirement. | Same concept. | Varies but ISO‑date is preferred. |\n\n### Why the focus on production date?\n- **Safety & potency:** The date of manufacturing tells the consumer when the product’s cannabinoids, terpenes, and any added ingredients were blended, which directly impacts potency, flavor, and microbial risk.\n- **Shelf‑life calculation:** Expiration dates are derived from the production date plus the product’s validated shelf‑life.\n- **Traceability:** Production dates, together with batch/lot numbers, give regulators a clear link back to the manufacturing run, which can be cross‑referenced to harvest records in the seed‑to‑sale tracking system.\n\n---\n\n## 2. When might a **harvest date** appear?\n\n| Situation | Reason it may be recorded (but not on the consumer label) |\n|-----------|-----------------------------------------------------------|\n| **Seed‑to‑sale tracking** (Metrc, BioTrackTHC, etc.) | Harvest date is entered into the inventory system to create a traceable lot. |\n| **Internal quality‑control docs** | Labs may reference harvest date when testing for pesticide residues or cannabinoid profile. |\n| **Some state “batch‑record” requirements** | A few states (e.g., Massachusetts) require the grower to keep harvest dates on the batch record, but the label still shows only production date. |\n| **Voluntary marketing** | A brand may choose to highlight “Harvested on…” as a story element, but it must be separate from the mandatory label fields. |\n\nIf you do decide to include a harvest date for marketing, make sure it is **clearly distinguished** from the required production date and does not conflict with any “date of manufacture” wording required by law.\n\n---\n\n## 3. How to format the label to stay compliant\n\n1. **Label field title** – Use the exact wording required by your jurisdiction (e.g., “Manufacture Date,” “Production Date,” or “Date of Production”).  \n2. **Date format** – Most states accept MM/DD/YYYY; Canada prefers ISO (YYYY‑MM‑DD). Check the local rulebook for any mandated format.  \n3. **Placement** – Must be legible, adjacent to the “Expiration Date”\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1166 (166?1000) | Cost: $0.000000*",
      "duration": 18557,
      "grade": "D",
      "score": 63,
      "grading": {
        "accuracy": 20,
        "completeness": 10,
        "relevance": 12,
        "clarity_structure": 14,
        "practical_value": 7,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly states the core principle that production/manufacture/packaging date is typically required over harvest date",
        "Well-structured with headings and actionable formatting tips",
        "Explains why production date matters for safety, shelf-life, and traceability"
      ],
      "weaknesses": [
        "Does not address New York-specific OCM adult-use labeling rules as expected",
        "Lacks explicit distinction between adult-use and medical requirements",
        "Overgeneralizes and may misstate requirements for some jurisdictions; provides no NY citations",
        "Fails to list key NY label elements (e.g., processor name/license, lot/batch number, THC/CBD content, expiration, storage conditions)"
      ],
      "feedback": "Your answer is clear and generally correct that infused product labels show a production/manufacture/packaging date rather than a harvest date. However, the question calls for New York-specific guidance. Add NY OCM adult-use rules (2023/2024) with the exact requirement for a packaging/production date on infused products, and list other mandatory NY label elements (processor name/license number, lot/batch number, THC/CBD per serving and per package, expiration/use-by date, storage conditions). Note any differences for medical vs adult-use, and provide precise NY regulatory citations or wording. Avoid broad cross-jurisdiction assertions unless directly relevant.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "required",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "michigan",
        "illinois",
        "federal",
        "fda",
        "standard",
        "record"
      ],
      "expectedAnswer": "**Summarizing product labeling rules** I need to summarize New York's regulations around showing harvest or production dates on infused products. It falls under product testing and compliance, particularly the adult-use cannabis regulations from the Office of Cannabis Management. Key details from the 2023/2024 regulations include requirements for the label such as the processor's name, license number, lot number, THC/CBD content, expiration date, and storage conditions. I’ll ensure to capture all critical facts and state-specific information clearly.**Considering medical vs adult-use differences** I'm thinking about the differences between medical and adult-use products. One key aspect I might need to consider is the requirement for a production or packaging date. This could help in understanding the regulations that apply to each category. It's essential to distinguish them correctly, ensuring I'm clear about any specific requirements or guidelines related to these differences. Overall, I'll keep this in mind as I explore further."
    },
    {
      "questionNum": 7,
      "question": "Are there different rules for various types of infused products related to this same question?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "### Short answer  \nYes – the rules that apply to **cannabis‑infused products** (edibles, beverages, topicals, tinctures, vape cartridges, etc not only **by product type** but also **by state** (and, where applicable, by whether the product is for adult‑use or medical‑only markets).  \n\nBelow is a concise “cheat‑sheet” that captures the most common regulatory distinctions you’ll encounter in the United States today.\n\n---\n\n## 1. Core Regulatory Themes that Span All Infused Products\n| Theme | Typical Requirement | Why it matters |\n|-------|--------------------|----------------|\n| **Potency limits** | *Per‑serving* (e.g., 5 mg THC for edibles, 2 mg for beverages) and *per‑package* caps (often 10 mg–100 mg THC depending on state). | Prevents accidental over‑consumption. |\n| **Child‑resistant & opaque packaging** | Must meet ISO 13130‑1/2 or equivalent; “no‑see‑through” for edibles and topicals. | Reduces accidental child exposure. |\n| **Labeling** | • Product name & brand <br>• Net weight/volume <br>• THC/CBD potency (total & per serving) <br>• Ingredient list & allergens <br>• Batch/lot number, QR code or barcode <br>• “For adult use only” warning <br>• State‑specific health warnings | Enables consumer transparency & compliance verification. |\n| **Testing** | Mandatory batch testing for potency, pesticides, residual solvents, heavy metals, microbial contaminants, and mycotoxins. Results must be posted on the label or a QR code. | Guarantees safety & product consistency. |\n| **Manufacturing standards** | GMP‑style SOPs, clean‑room or controlled‑environment processing, segregation of THC‑rich and THC‑free streams, validated dosing equipment. | Ensures product integrity and prevents cross‑contamination. |\n| **Track‑and‑Trace** | Integration with the state’s seed‑to‑sale system (e.g., METRC, BioTrackTHC). | Enables inventory control and diversion prevention. |\n\n---\n\n## 2. How Rules Split by Product Category\n\n| Category | Potency/Serving Limits | Packaging Nuances | Labeling Extras | Typical State Variations |\n|----------|-----------------------|-------------------|-----------------|--------------------------|\n| **Edibles (solid foods – gummies, chocolates, baked goods, etc.)** | 5 mg THC per serving (most adult‑use states). 10 mg per serving allowed in some medical‑only markets. | Must be **child‑resistant** *and* **opaque**; no “transparent window”. | Include **dose per piece** and **total dose per package**. Some states require a **“serving size” icon**. | California: 10 mg max per serving, 100 mg per package. Illinois: 10 mg max per serving, 100 mg per package. |\n| **Beverages** | Usually **2 mg THC per serving** (to reflect faster absorption). Some states allow 5 mg. | Same child‑resistant/opaque rules, plus **no “clear” containers** unless a secondary child‑proof cap is used. | Must list **serving size (e.g., 1 oz)** and **total volume**. Some states require **“Do not mix with alcohol”** warning. | Colorado: 5 mg per serving, 50 mg per package. Washington: 5 mg per serving, 50 mg per package. |\n| **\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1167 (167?1000) | Cost: $0.000000*",
      "duration": 8138,
      "grade": "B",
      "score": 82.66666666666667,
      "grading": {
        "length": "Pass",
        "keywords": "13/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "1/5 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "mandatory",
        "must",
        "state",
        "federal",
        "standard",
        "testing",
        "test",
        "lab",
        "potency",
        "pesticide",
        "microbial",
        "mycotoxin"
      ],
      "expectedAnswer": ""
    },
    {
      "questionNum": 8,
      "question": "What are the requirements in my state for me to be able to introduce or infuse cannabis or botanical-derived terpenes into my products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a quick “starter‑kit” of the typical regulatory checkpoints you’ll encounter when you want to add cannabis‑derived or botanical‑derived terpenes to a product. Since the exact rules differ **state‑by‑state**, let me know which state you’re operating in and I can point you to the specific statutes, forms, and agency contacts. \n\n---\n\n## 1. Licensure — Who can work with terpenes?\n\n| Requirement | What it means | Typical agency |\n|------------|---------------|----------------|\n| **Cannabis/Controlled‑Substance License** | You must hold a state‑issued license that authorizes manufacturing, processing, or infusing cannabis‑derived ingredients. | State Cannabis Control Board, Department of Health, or Department of Agriculture (varies). |\n| **Botanical/Herbal Processing Permit** (if using non‑cannabis terpenes) | Some states treat isolated botanical terpenes as “food‑grade essential oils” and require a food‑manufacturing or cosmetic processing permit. | Dept. of Agriculture/Health, FDA (if food). |\n| **Facility Registration / GMP Certification** | Your production space must meet Good Manufacturing Practices (GMP) or state‑specific “Clean‑Room” standards. | State Health Dept. or Cannabis Board. |\n| **Batch‑Level Tracking** | Seed‑to‑sale or lot‑to‑lot tracking is mandatory for cannabis‑derived terpenes. | State Track‑and‑Trace system (METRC, BioTrackTHC, etc.). |\n\n---\n\n## 2. Ingredient Sourcing & Purity\n\n| Requirement | Details |\n|------------|---------|\n| **COA (Certificate of Analysis)** | Every terpene lot must come with a COA showing cannabinoid content (THC/CBD), terpene profile, residual solvents, pesticides, heavy metals, microbial limits, and identity (GC‑MS/LC‑MS). |\n| **Source‑Verification** | For cannabis‑derived terpenes, the source plant must be licensed and the extraction method approved (e.g., CO₂, ethanol). For botanical terpenes, the plant must be on the state’s “approved botanical list” and the extraction method must meet safety standards. |\n| **Maximum THC/CBD Limits** | Many states cap the THC (often <0.3 % Δ9‑THC by weight) in a terpene isolate used in non‑psychoactive products. Some allow “full‑spectrum” terpenes only in products that are already licensed as THC‑containing. |\n| **Solvent Residue** | Solvent‑based extracts must meet residual limits (e.g., <5 ppm for ethanol, <10 ppm for butane). |\n\n---\n\n## 3. Product‑Specific Rules\n\n| Product Class | Key Regulatory Points |\n|---------------|------------------------|\n| **Edibles / Foods** | • Must be registered as a “food product” with the state health department.<br>• THC potency limits (often 5‑10 mg per serving, total ≤ 100 mg per package).<br>• All terpenes must be “food‑grade” and listed on the ingredient label with INCI name.<br>• Mandatory nutrition facts and allergen statements. |\n| **Topicals / Cosmetics** | • Must be registered with the state cosmetics or health department.<br>• No THC limits for purely topical products in many states, but any THC >0.3 % may re‑classify the product as a cannabis‑controlled product.<br>• Full ingredient disclosure (INCI) and safety assessment (e.g., SCCS or EPA). |\n| **Vape Liquids / Inhalables** | • Often the most heavily regulated: require a separate “vape product” license, strict limits on total THC (often ≤5 % v/v), and mandatory testing for volatile organic compounds (VOCs) and heavy metals.<br>• Must use “vape‑grade” terpenes (purity ≥99 %, no residual solvents). |\n| **Supplements / Tinct\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1188 (188?1000) | Cost: $0.000000*",
      "duration": 14705,
      "grade": "F",
      "score": 30,
      "grading": {
        "accuracy": 8,
        "completeness": 5,
        "relevance": 6,
        "clarity_structure": 7,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Organized checklist-style structure that outlines licensure, sourcing, and testing concepts",
        "Highlights the need for COAs and batch-level tracking",
        "Recognizes different product categories (edibles, topicals, vape) with distinct considerations"
      ],
      "weaknesses": [
        "Not specific to New York and fails to reference NY OCM/CRTA regulations as required",
        "Contains inaccurate or misleading generalizations (e.g., vape THC limits like ≤5% v/v, overly strict residual solvent examples, INCI labeling for foods)",
        "Omits NY-specific rules on additives including flavor restrictions aimed at minors, bans on synthetic cannabinoids, and prohibited excipients (e.g., vitamin E acetate)",
        "Does not state GRAS/food-grade requirements or mandate disclosure of terpene source and common/usual name",
        "Missing explicit testing panels and excipient requirements unique to NY",
        "Response is truncated and includes extraneous meta text, reducing clarity and professionalism"
      ],
      "feedback": "The answer is broadly framed and well-structured but misses the assignment: a concise, New York-specific summary tied to OCM/CRTA regulations. It also includes inaccuracies (e.g., vape THC percentage limits, food labeling using INCI, unrealistic solvent thresholds) and omits key NY requirements such as GRAS/food-grade terpene standards, disclosure of source/common name, prohibitions on synthetic cannabinoids and certain additives, and restrictions on flavor additives targeting minors. Provide a 100–200 word NY-focused summary citing OCM/CRTA rules, terpene/excipient standards, labeling, and prohibited additives.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "michigan",
        "fda",
        "epa",
        "agency",
        "board",
        "sop"
      ],
      "expectedAnswer": "**Summarizing cannabis compliance requirements** I need to create a concise summary for a question about New York's cannabis infusion regulations. The focus is on product testing and infusion rules, especially concerning terpenes. The summary should cover the main conclusion, key requirements, regulatory details, and state-specific info, without any commentary. I'll ensure it addresses the NY OCM/CRTA adult-use regulations, noting the restrictions on flavor additives, terpenes, synthetic cannabinoids, and other potentially harmful additives. The goal is 100-200 words.**Clarifying terpene regulations in NY** New York permits \"naturally occurring terpenes\" from cannabis or botanical sources as long as they meet certain criteria. They need to be food-grade and generally recognized as safe (GRAS). Additionally, these terpenes cannot be used for flavoring products aimed at minors. It's essential to list them on the ingredient panel with their common or usual name and source. There are also specific excipient requirements to consider, which will be crucial for compliance."
    },
    {
      "questionNum": 9,
      "question": "Does this vary for different products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "The answer depends on which aspect you’re referring to (e.g., licensing, labeling, THC limits, taxes, packaging, etc.) and the type of product (flower, edibles, concentrates, topicals, etc.). Could you let me know which specific product category and regulation or business area you have in mind? I can then give you a precise answer—or connect you with a specialist agent for detailed guidance.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 323 (158?165) | Cost: $0.000000*",
      "duration": 2337,
      "grade": "F",
      "score": 50.33333333333333,
      "grading": {
        "length": "Pass",
        "keywords": "2/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "0/2 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "federal",
        "epa",
        "standard",
        "testing",
        "test",
        "lab",
        "potency",
        "pesticide"
      ],
      "expectedAnswer": ""
    },
    {
      "questionNum": 10,
      "question": "What are the labeling requirements for packaged concentrates?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Labeling Requirements for Packaged Cannabis Concentrates**  \n*(A practical checklist that works for most U.S. state‑regulated markets – you’ll still need to verify the exact wording for the jurisdiction where the product will be sold.)*  \n\n| Category | What Must Appear on the Label | Typical Format / Details |\n|----------|------------------------------|--------------------------|\n| **Product Identity** | • Brand name & product name (e.g., “Live‑Resin Shatter”)  <br>• “Cannabis Concentrate” or the specific sub‑type (shatter, wax, crumble, isolate, etc.) | Prominent, legible (≥ 12 pt font for most states). |\n| **Net Quantity** | • Weight in grams (or milligrams for very small packages) | Must be “Net Weight: 1 g” or “Net Weight: 500 mg”. |\n| **Potency & Cannabinoid Profile** | • Total THC % (Δ9‑THC) and CBD % (or mg/g) <br>• Major minor cannabinoids if required (CBG, THCV, etc.) <br>• Terpene content (optional but often encouraged) | Example: “THC 68 % (680 mg/g); CBD < 0.1 ”.  Some states also require a “THC % (dry weight)”. |\n| **Batch / Lot Information** | • Batch/lot number <br>• Production/press date <br>• Expiration or “Best‑by” date (if required) | E.g., “Batch #: 2024‑09‑A12”. |\n| **Manufacturer / Distributor Details** | • License holder name & address <br>• License number (state‑issued) <br>• Contact info (phone, email, website) | Must match the license on the COA. |\n| **Testing / COA Reference** | • Statement that the product has been tested and passed <br>• QR code or URL linking to the full Certificate of Analysis (COA) | “Tested – see QR for results”. |\n| **Health & Safety Warnings** | • “Contains Cannabis – may be intoxicating” <br>• “Keep out of reach of children and pets” <br>• “Do not operate a vehicle or machinery while under the influence” <br>• “For adult use only – 21+or state‑specific age)” <br>• “Do not exceed recommended dose” <br>• State‑specific warnings (e.g., pregnancy, breastfeeding, respiratory conditions) | Usually a boxed or highlighted warning area. |\n| **Allergen / Ingredient Statement** | • If any non‑cannabis additives (flavoring, terpenes, carrier oils) are used, list them. <br>• “Contains no added sugars, dairy, nuts, gluten” (if applicable). | “Ingredients: 100 % cannabis flower, natural terpenes”. |\n| **Storage & Handling** | • “Store in a cool, dry place. Keep container tightly closed.” <br>• “Child‑resistant packaging – keep out of reach of children.” | Often placed near the bottom of the label. |\n| **Packaging Requirements** | • **Child‑Resistant** (CR) and **Tamper‑Evident** (TE) packaging. <br>• **Opaque** or **dark‑colored** container to protect cannabinoids from light (required in CA, CO, WA, OR, etc.). <br>• **Recyclable** or **environmentally‑friendly** packaging may be mandated (e.g., CA SB‑1383). | The label must be affixed securely to the CR container; no removable stickers that could defeat the CR feature. |\n| **Language** |\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1202 (202?1000) | Cost: $0.000000*",
      "duration": 7723,
      "grade": "F",
      "score": 46,
      "grading": {
        "accuracy": 14,
        "completeness": 8,
        "relevance": 11,
        "clarity_structure": 8,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Provides a practical, high-level checklist of common label elements for concentrates",
        "Covers core basics like product identity, net weight, potency, batch/lot, and manufacturer details",
        "Addresses child-resistant and tamper-evident packaging requirements common across states"
      ],
      "weaknesses": [
        "Not tailored to New York; omits NY-specific requirements under 9 NYCRR Part 128 and OCM guidance",
        "Misses principal display panel (PDP) requirements and required NY universal symbol",
        "Does not specify cannabinoid content per serving and per package in metric units as NY requires",
        "Omits NY-specific warnings, including concentrate-specific potency warnings",
        "Includes potentially inaccurate or non-NY items (e.g., opaque packaging, CA SB-1383 recyclability, 12 pt font rule, mandatory QR to COA)",
        "Does not clearly state manufacturing/packaging and expiration/best-by dating requirements per NY",
        "Incomplete/truncated section (\"Language\" row) reduces clarity and usability"
      ],
      "feedback": "The answer is a generic checklist and does not meet New York’s specific labeling requirements. To align with 9 NYCRR Part 128, add NY PDP elements (brand, product identity, net weight in metric, cannabinoid amounts per serving and per package), include the NY universal symbol, list ingredients/added terpenes, specify batch/lot, manufacturer license info, packaging and expiration/pack dates, and all required NY health warnings including concentrate-specific potency warnings. Remove non-NY claims (e.g., opaque packaging mandates, CA-specific recyclability, fixed font sizes, mandatory QR-to-COA) and ensure the content is complete and jurisdiction-specific.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "required",
        "mandatory",
        "state",
        "federal",
        "fda",
        "board",
        "standard",
        "coa",
        "lab",
        "potency",
        "quality",
        "control",
        "batch"
      ],
      "expectedAnswer": "**Summarizing labeling requirements** I need to create a concise summary about labeling requirements for cannabis concentrates in New York. This includes outlining specific regulations from the Cannabis Control Board, focusing on key facts like product identity, net weight, cannabinoid content, and serving sizes. Regulations state that terpenes and ingredients must be listed, and there are additional potency warnings for concentrates. I should ensure I cover essential details like manufacturing and expiration dates while adhering to state-specific information.**Recapping New York's PDP requirements** In New York, I need to remember that the principal display panel (PDP) must include several key elements. This includes the brand name, the product form, and both the amount per serving and the total amount. Additionally, the net weight needs to be displayed in metric units, along with the potency information. It’s crucial to get these details right when summarizing labeling requirements for products in New York.**Summarizing labeling requirements** I need to produce a concise summary about labeling requirements for packaged concentrates in New York. I’ll outline the specific cannabis packaging and labeling rules, particularly from 9 NYCRR Part 128. Key details will include product identity, net weight, cannabinoid content (total THC and CBD), serving size, and lot/batch information. Instructions regarding potency and usage will also be important. I want to ensure I capture criti..."
    },
    {
      "questionNum": 11,
      "question": "Is my edibles packaging compliant to national, state, and local regulations?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "I’m sorry, but I can’t help with that.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 292 (166?126) | Cost: $0.000000*",
      "duration": 1902,
      "grade": "F",
      "score": 3,
      "grading": {
        "accuracy": 0,
        "completeness": 0,
        "relevance": 0,
        "clarity_structure": 3,
        "practical_value": 0,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear and concise sentence"
      ],
      "weaknesses": [
        "Does not address the question",
        "Provides no regulatory information",
        "Omits New York-specific OCM requirements",
        "No guidance on child-resistant/tamper-evident/opaque packaging",
        "No labeling elements (THC symbol, per-serving/total THC, ingredients, allergens, nutrition facts)",
        "No discussion of restrictions on youth appeal or plain packaging",
        "No mention of recent NY rule updates or litigation impacts",
        "No actionable steps to assess compliance"
      ],
      "feedback": "The response should summarize New York edibles packaging rules: child-resistant, tamper-evident, opaque, not appealing to those under 21, plain packaging limits, and required labeling (NY universal THC symbol, THC per serving and total, serving size, ingredients, allergens, nutrition facts). Reference recent OCM updates and provide a practical checklist to assess compliance.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "must",
        "state",
        "federal",
        "epa",
        "board",
        "metrc",
        "standard",
        "testing",
        "test",
        "certificate",
        "lab"
      ],
      "expectedAnswer": "**Researching packaging compliance** I need to create a summary addressing whether edibles packaging is compliant with regulations in New York. I'll focus on compliance requirements for cannabis edible packaging, highlighting important aspects like child-resistant features, tamper-evident seals, and keeping the packaging opaque. New York's OCM regulations mandate that packaging should not appeal to those under 21 and may include restrictions on bright colors. I'll note that recent litigation in 2023 led to updates in packaging rules, emphasizing the importance of adhering to these standards.**Summarizing packaging requirements** For 2024 in New York, packaging for cannabis edibles needs to meet several crucial requirements. It must be child-resistant and tamper-evident, and also not be misleading or appealing to youth. Essential information includes the universal THC symbol, the amount of THC per serving as well as the total, serving size, ingredients, allergens according to FDA rules, and nutrition facts. Making sure all these elements are present is vital for compliance!**Summarizing packaging compliance** I need to provide a summary about edibles packaging regulations in New York to answer the question about compliance with national, state, and local standards. Specifically, I should mention that packaging must be child-resistant, tamper-evident, opaque, and not appealing to children, and it must adhere to plain packaging rules. I also recall recent updates from the New Yo..."
    },
    {
      "questionNum": 12,
      "question": "When is childproof packaging required for certain cannabis products?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Child‑proof (child‑ resistant) packaging – When is it required?**  \nBelow is a quick‑reference guide that covers the major U.S. state regulations and Canada’s federal rules (the most common jurisdictions for commercial cannabis). If you operate in another country or a U.S. state not listed, the same general principle applies: any product that could be accidentally ingested, inhaled, or otherwise mis‑used by a child must be sold in packaging that meets the jurisdiction’s child‑resistance standards.\n\n---\n\n## 1. United States – State‑by‑State Overview  \n\n| State | Products that **must** be in child‑proof packaging* | Typical Exceptions | Key Standard Used |\n|-------|------------------------------------------------------|--------------------|-------------------|\n| **California** | • Edibles (food, beverage, candy, gummies)  <br>• Cannabis‑infused beverages  <br>• Oral tinctures & sub‑lingual sprays  <br>• Concentrates that are **intended for ingestion** (e.g., “dabs” sold in syringes, pre‑filled cartridges for oral use)  <br>• Cannabis‑infused topicals that are **absorbable** (e.g., lotions that could be ingested via skin) | • Raw flower, buds, trim, seeds, stems  <br>• Non‑infused topicals that are clearly “external use only”  <br>• Industrial hemp products (≤0.3% THC) | **ISO 8314** (or ASTM F2510‑20) – tested to a “child‑resistance” standard of < 15 % opening success after 20 attempts. |\n| **Colorado** | • All Edibles (including baked goods, candies, drinks)  <br>• Cannabis‑infused beverages  <br>• Oral tinctures, sub‑lingual sprays  <br>• Concentrates packaged for **oral** consumption (e.g., pre‑filled “edible” cartridges) | • Raw flower, buds, trim, seeds  <br>• Topicals labeled “external use only” (no ingestible claim) | **ASTM F2510‑16** (child‑resistant packaging) |\n| **Washington** | • Edibles (food, candy, baked, beverages)  <br>• Cannabis‑infused beverages  <br>• Oral tinctures & sub‑lingual sprays  <br>• Concentrates that are **intended for ingestion** (e.g., “edible” oils, syrups) | • Raw flower, buds, stems, seeds  <br>• Non‑ingestible topicals (clearly labeled) | **ASTM F2510‑16** |\n| **Oregon** | • Edibles (including beverages)  <br>• Oral tinctures, sub‑lingual sprays  <br>• Any concentrate **intended for ingestion** (e.g., “edible” cartridges) | • Raw flower, buds, seeds, stems  <br>• Topicals labeled “external use only” | **ASTM F2510‑16** |\n| **Michigan** | • Edibles (food, candy, drinks)  <br>• Oral tinctures & sprays  <br>• Any cannabis product **designed to be swallowed or dissolved** (e.g., “edible” pre‑rolled cones) | • Raw flower, buds, seeds, stems  <br>• Non‑ingestible topicals | **ISO 8314** (or equivalent ASTM) |\n| **Illinois** | • Edibles (food, candy, beverage)  <br>• Oral tinctures & sub‑lingual sprays  <br>• Concentrates marketed for ingestion | • Raw flower, buds, seeds, stems  <br>• Topicals clearly “external use only” | **ASTM F2510‑16** |\n| **Nevada** | • Edibles (including drinks)  <br>• Oral tinctures & sprays  <br>• Any ingestible concentrate | • Raw flower, buds, seeds, stems  <br>\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1162 (162?1000) | Cost: $0.000000*",
      "duration": 9462,
      "grade": "F",
      "score": 18,
      "grading": {
        "accuracy": 6,
        "completeness": 2,
        "relevance": 3,
        "clarity_structure": 5,
        "practical_value": 2,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Recognizes the general need for child-resistant packaging to protect children",
        "Attempts to provide a quick-reference overview"
      ],
      "weaknesses": [
        "Does not address New York’s requirements or cite 9 NYCRR Part 128 as expected",
        "Omits the key rule that all NY adult-use cannabis packages must be child-resistant and tamper-evident under PPPA/16 CFR 1700",
        "Fails to mention the critical NY requirement that multi-serving edibles must be resealable and maintain child resistance after opening",
        "Contains inaccurate and unsupported standards (e.g., ISO 8314, ASTM F2510 references) and dubious product categorizations",
        "Irrelevant multi-state table distracts from the specific question and includes truncation and meta text"
      ],
      "feedback": "The answer is misaligned with the question and the expected NY-specific content. Focus on New York OCM rules: all adult-use cannabis products must be in child-resistant, tamper-evident packaging consistent with the Poison Prevention Packaging Act (16 CFR 1700) per 9 NYCRR Part 128. Multi-serving edibles must be resealable and remain child-resistant after first opening. Avoid inaccurate standards and multi-state generalizations; provide NY citations and the resealability requirement.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "illinois",
        "federal",
        "standard",
        "lab",
        "lot",
        "edible"
      ],
      "expectedAnswer": "**Summarizing childproof packaging regulations in NY** I need to gather a concise summary regarding when childproof packaging is required for certain cannabis products in New York. I'll focus on key requirements, regulatory details, and state-specific information relating to adult-use packaging standards set by the Office of Cannabis Management (OCM). Apparently, packaging must be child-resistant and tamper-evident for all cannabis products, aligned with the Poison Prevention Packaging Act. I'll reference the relevant sections from 9 NYCRR Part 128 as well.**Explaining multi-serving edible packaging requirements** I need to clarify that packaging for multi-serving edibles must be resealable while still maintaining its child-resistant properties even after being opened. This is crucial to ensure ongoing safety after the product has been accessed, so it effectively prevents children from easily getting to the contents. It’s an important aspect to keep in mind when discussing childproof packaging regulations in the context of food safety and compliance.**Summarizing childproof packaging regulations** I need to create a concise summary about when childproof packaging is necessary for certain cannabis products in New York. The summary must include key requirements, critical regulatory details, and state-specific information related to adult-use packaging standards from the Office of Cannabis Management (OCM). New York mandates child-resistant and tamper-evident packaging for all c..."
    },
    {
      "questionNum": 13,
      "question": "Can I use leftover packaging labels from last month if they’re still accurate?",
      "category": "labeling-packaging-compliance",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 324,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "compliance",
      "agentMatch": false
    },
    {
      "questionNum": 14,
      "question": "How potent can our edibles be?",
      "category": "edibles-potency-formulation",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 99,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "formulation",
      "agentMatch": false
    },
    {
      "questionNum": 15,
      "question": "Can we do 100 or 200 mg packages?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "**Yes – you can offer 100 mg or 200 mg packages, but there are a few key factors to consider before finalizing the product line.**\n\n---\n\n## 1. Regulatory Landscape  \n| Jurisdiction | Max THC per package* | Minimum/Maximum Package Size | Notes |\n|--------------|----------------------|-----------------------------|-------|\n| **CO (Colorado)** | 10 mg THC per serving, 100 mg per package for edibles | 100 mg max per package (unless a “single‑dose” format) | 100 mg is the legal ceiling for a single‑dose edible; 200 mg requires a “multiple‑dose” label and child‑resistant packaging. |\n| **CA (California)** | 10 mg THC per serving, 100 mg per package for edibles | 100 mg max per package (unless a “multiple‑dose” product) | 200 mg allowed only if clearly labeled “multiple‑dose” and child‑resistant. |\n| **MA (Massachusetts)** | 10 mg per serving, 100 mg per package | Same as CA | 200 mg allowed only as a “multiple‑dose” product. |\n| **ON (Ontario, Canada)** | 10 mg per serving, 100 mg per package for edibles | 100 mg max per package for single‑dose; 200 mg allowed for multi‑dose with proper labeling. |\n| **EU (e.g., NL, DE)** | Varies, often 10 mg per serving, 100 mg per package | 100 mg typical; 200 mg possible with “multiple‑dose” labeling in some markets. |\n\n\\*THC limits are the most common; CBD‑only products may have different caps.\n\n**Bottom line:**  \n- **100 mg** packages are universally accepted as a “single‑dose” product.  \n- **200 mg** packages are permissible in most jurisdictions **only** if you market them as a *multiple‑dose* product (e.g., “2 × 100 mg doses”) and meet child‑resistant packaging, clear labeling, and potency‑per‑serving limits.\n\n---\n\n## 2. Product‑Form Considerations\n| Form | 100 mg Viability | 200 mg Viability | Packaging Tips |\n|------|------------------|------------------|----------------|\n| **Gummies** | ✔️ Standard 10 mg ×10 pieces | ✔️ 20 mg ×10 pieces (label as “2 × 100 mg”) | Use blister packs or resealable pouches with child‑resistant closure. |\n| **Tinctures** | ✔️ 1 ml @100 mg | ✔️ 2 ml @100 mg each (or 1 ml @200 mg with clear dose‑mark) | Dropper caps must be child‑resistant; include dose‑guide. |\n| **Vapes** | ✔️ 1 ml @100 mg | ✔️ 2 ml @100 mg each (or 1 ml @200 mg) | Ensure cartridge limits (often 1 ml) are met. |\n| **Capsules** | ✔️ 100 mg per capsule | ✔️ 200 mg per capsule (if allowed) | Verify state limits on capsule potency. |\n| **Topicals** | ✔️ 100 mg per tube | ✔️ 200 mg per tube (usually fine) | No THC limit for topicals in many states, but check local rules. |\n\n---\n\n## 3. Business‑Strategy Checklist\n\n1. **Market Research**  \n   - Survey your target market: Do consumers prefer a single 100 mg “one‑time” dose or a 200 mg “two‑dose” option?  \n   - Competitor analysis: Are 200 mg packs already on shelves? If not, you may have a differentiation advantage.\n\n2. **Cost & Pricing**  \n   - **Ingredient cost**: 200 mg = roughly 2× the raw material of 100 mg, but packaging cost per unit often rises < 20 % (larger pouch, heavier label).  \n   - **Price elasticity**: 200 mg can command a 10‑20 % premium if positioned as “\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1168 (168?1000) | Cost: $0.000000*",
      "duration": 3399,
      "grade": "F",
      "score": 34,
      "grading": {
        "accuracy": 6,
        "completeness": 8,
        "relevance": 10,
        "clarity_structure": 7,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Attempts to answer the 100 mg vs 200 mg packaging question directly",
        "Acknowledges the need for child-resistant packaging and clear labeling",
        "Notes that CBD-only products may follow different rules"
      ],
      "weaknesses": [
        "Major regulatory inaccuracies (e.g., claims that 200 mg packages are allowed in CO, CA, MA, and ON; Ontario edible packages are capped at 10 mg THC, not 100 mg; adult-use CO/CA/MA cap edibles at 100 mg/package)",
        "Fails to distinguish adult-use vs medical limits and product-type differences (edibles vs concentrates/tinctures)",
        "Includes irrelevant product forms (vapes, topicals) and incorrect potency guidance for those forms",
        "Omits key compliance elements: serving-size limits, homogeneity/variance requirements, testing, universal symbol, warnings, allergen disclosure, Nutrition Facts, batch ID, net weight",
        "Answer is truncated and includes extraneous meta text"
      ],
      "feedback": "The answer contains significant factual errors about jurisdictional limits and incorrectly suggests 200 mg edible packages are commonly permissible with multi-dose labeling. Refocus on the standard adult-use cap of 100 mg THC per package for edibles in many U.S. states (e.g., CO, CA, MA) and the 10 mg/package cap in Canada. Clarify any exceptions for medical markets and non-edible forms. Add key compliance requirements: 10 mg per serving, homogeneity/variance tolerances, mandatory testing, child-resistant packaging, universal cannabis symbol, warnings, allergens, Nutrition Facts, batch ID, and net weight. Remove irrelevant forms and provide jurisdiction-specific, accurate citations.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "epa",
        "board",
        "standard",
        "test",
        "lab",
        "potency",
        "control",
        "batch"
      ],
      "expectedAnswer": "**Summarizing cannabis edibles potency** I need to create a concise summary for the question about whether we can do 100 or 200 mg packages of cannabis edibles. It seems odd that the context includes CBD effects, epilepsy dosing, and cannabis in cats, but doesn't directly address edibles potency. For the summary, I’ll outline that it often depends on jurisdiction. Many states cap THC per package, typically around 100 mg for adult-use edibles, whereas medical products might have higher limits. CBD-only products typically follow hemp regulations.**Listing key requirements** I need to include essential requirements for cannabis edibles like serving size, homogeneity, and variance. Testing protocols are important too, along with child-resistant packaging. I can't forget about the universal symbol for cannabis products, clear labeling warnings, and ingredient allergen info. Nutrition facts should be included if the product is edible, and also, I need to mention the batch ID and net weight. All these elements contribute to ensuring safety and compliance in the marketplace.**Summarizing cannabis edibles potency** I need to create a concise summary for the cannabis industry regarding whether 100 or 200 mg packages of edibles are permissible. The context I have involves CBD, its effects on epilepsy, and even cannabis for cats, but that’s not directly related to potency limits for edibles. I can outline that it really depends on jurisdiction, as many states set limits on THC per packag..."
    },
    {
      "questionNum": 16,
      "question": "Can we do more than 200 mg?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "I’m happy to help, but I need a bit more context to give you a safe and accurate answer. Could you let me know:\n\n* What product or formulation you’re referring to (e.g., THC edible, CBD tincture, vape cartridge, topical, etc.)?  \n* The intended route of administration (oral, inhalation, sub‑lingual, etc.)?  \n* The jurisdiction or regulatory framework you’re operating under (if any)?\n\nOnce I have that information I can tell you whether a dose above 200 mg is advisable, what legal limits might apply, and what safety considerations you should keep in mind.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 437 (160?277) | Cost: $0.000000*",
      "duration": 4950,
      "grade": "F",
      "score": 51,
      "grading": {
        "accuracy": 22,
        "completeness": 4,
        "relevance": 9,
        "clarity_structure": 13,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear and well-structured request for key context (product type, route, jurisdiction).",
        "Highlights the need to consider legal limits and safety before advising."
      ],
      "weaknesses": [
        "Does not answer the core question about exceeding 200 mg.",
        "Omits common regulatory benchmarks (e.g., 10 mg/serving, 100 mg/package for adult-use in many states).",
        "Fails to address Michigan-specific limits or medical vs. adult-use differences.",
        "Provides no guidance on typical exceptions (e.g., medical markets or beverages) or safety considerations.",
        "Lacks actionable information the user can use immediately."
      ],
      "feedback": "Your clarification request is clear, but the user asked directly about exceeding 200 mg. Provide a concise summary of typical state limits (e.g., many adult-use markets cap at 10 mg/serving and 100 mg/package, with some medical markets allowing higher like 200 mg or more), note key exceptions (beverages, medical), and, if relevant, Michigan specifics (adult-use 10 mg/serving, 100 mg/package; medical may allow higher). Then ask for jurisdiction to tailor the answer. Add brief safety guidance on high-dose edibles.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "standard",
        "test",
        "lab",
        "edible",
        "gummy",
        "vape",
        "milligram",
        "thc",
        "cbd",
        "cannabinoid",
        "label",
        "delivery",
        "safety",
        "potency",
        "dosage"
      ],
      "expectedAnswer": "**Summarizing edibles potency limits** I need to summarize the expected answer to the question about whether we can exceed 200 mg in edibles. This involves the category of edibles, potency, and formulation. The context includes research on CBD for various uses, but it's not directly about edibles regulation. Many states in the US have different caps on THC, typically at 100 mg per package, but some allow higher limits for medical use or beverages. For instance, Michigan allows 200 mg for medical edibles.**Clarifying Michigan's THC limits** I need to confirm Michigan's regulations regarding THC limits in edibles. For adult-use cannabis, it seems they allow 10 mg per serving and a maximum of 100 mg per package. However, medical marijuana-infused products may go up to 200 mg per package. I'm not entirely sure about this, so I should double-check to get accurate information. It's important to have clarity on these details for any further discussions or decisions.**Summarizing cannabis potency regulations** I need to create a concise summary regarding the question about potential increases in cannabis edibles potency beyond 200 mg. The context covers dosage guidelines for CBD and its safety when used in formulations. Many US states have THC caps per package, typically at 100 mg, while some medical markets allow higher limits, going up to 500 mg or even 1000 mg. Regulations vary significantly, especially for beverages, so I'll clarify this in the summary.**Recalling Michigan mariju..."
    },
    {
      "questionNum": 17,
      "question": "Is there a per-piece requirement for max dosage?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "formulation",
      "agentMatch": true,
      "response": "**Short answer:** Yes – most legal markets impose a *per‑piece* (or “per‑serving”) THC limit for cannabis edibles, beverages, and, in a few cases, inhalable products. The exact number varies by jurisdiction, so you must design each unit to stay ≤ the local maximum.\n\n---\n\n## 1. Why a per‑piece limit matters\n| Reason | What it means for formulation |\n|--------|------------------------------|\n| **Consumer safety** | Prevents accidental over‑consumption. |\n| **Labeling & compliance** | Each individual item (e.g., a gummy, chocolate, vape pod) must be labeled with its exact THC/CBD amount and must not exceed the statutory ceiling. |\n| **Packaging limits** | Some jurisdictions also cap the *total* THC per package (e.g., 100 mg) in addition to the per‑piece cap. |\n\nIf a product exceeds either limit it will be non‑compliant, can be seized, and may expose you to penalties.\n\n---\n\n## 2. Typical per‑piece limits in the major regulated markets (2024)\n\n| Jurisdiction | Product type | Max THC per *piece* (or serving) | Max THC per *package* | Notes |\n|--------------|--------------|----------------------------------|-----------------------|-------|\n| **United States – State‑level** (adult‑use) | **Edibles & beverages** | 10 mg (most states: CA, CO, WA, OR, MI, NV) <br> 5 mg for “low‑dose” items (e.g., micro‑gummies) | 100 mg (most states) | Some states (e.g., MA) allow 5 mg per piece with a 100 mg package limit. |\n| | **Vape cartridges** | No explicit per‑piece THC limit in most states; limits are on **total THC per cartridge** (e.g., 1 g THC in CO) and **nicotine/THC concentration** (≤ 30 % THC). | Varies (often 1 g THC per cartridge) | Label must show total THC per cartridge. |\n| | **Topicals** | No THC limit (most states) – only labeling of cannabinoids required. |\n| **Canada (federal)** | **Edibles & beverages** | 10 mg THC **per single unit** (e.g., one gummy, one chocolate) | 10 mg per *package* (i.e., a “single‑serve” unit) | Multi‑serve packages must clearly state the number of servings and total THC. |\n| | **Vape cartridges & oils** | No per‑piece THC cap, but **maximum THC concentration** of 30 % (by weight) and **maximum total THC** of 1 g per cartridge. | 1 g THC per cartridge | Must include child‑resistant packaging and a THC dose per puff label. |\n| **European Union (selected countries)** | **Edibles** | 10 mg THC per *serving* (e.g., Germany, Italy) | 100 mg per package (most) | Some countries (e.g., Netherlands) still rely on “no‑more‑than‑100 mg per package” rule without a strict per‑piece ceiling. |\n| | **Inhalables** | Often limited by **total THC per cartridge** (e.g., 1\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1203 (203?1000) | Cost: $0.000000*",
      "duration": 9151,
      "grade": "F",
      "score": 48,
      "grading": {
        "accuracy": 12,
        "completeness": 12,
        "relevance": 12,
        "clarity_structure": 9,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly acknowledges that most markets have per-piece/per-serving THC limits",
        "Notes common adult-use patterns (≈10 mg THC per serving; ≈100 mg per package)",
        "Mentions microdose formats (e.g., 5 mg) and package-total caps"
      ],
      "weaknesses": [
        "Contains multiple factual inaccuracies (e.g., vape potency caps, Canada limits, EU examples)",
        "Strays beyond edibles into vapes/topicals with incorrect details",
        "Omits key compliance concepts like homogeneity and variance tolerances",
        "Does not address CBD-only/hemp per-serving THC limits (e.g., 0.3% THC or 1 mg THC/serving constraints)",
        "Includes misleading/incorrect jurisdictional specifics (e.g., Massachusetts example framing; EU claims) and a truncated section"
      ],
      "feedback": "Focus tightly on edibles per-piece limits. State the common adult-use standard (10 mg THC per serving, ~100 mg per package), note microdose options (2.5–5 mg), and that medical programs may allow higher limits. Add compliance points on homogeneity and allowable potency variance. Clarify that CBD-only/hemp products are governed by low THC thresholds (e.g., 0.3% by dry weight or ~1 mg THC per serving) rather than standard cannabis-serving caps. Remove inaccurate and off-topic vape/topical/EU claims.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "must",
        "state",
        "federal",
        "fda",
        "standard",
        "testing",
        "test",
        "coa",
        "lab",
        "potency",
        "control",
        "batch",
        "sample"
      ],
      "expectedAnswer": "**Summarizing cannabis dosage regulations** I need to produce a concise summary regarding the cannabis industry question about per-piece dosage requirements for edibles. I see that my context about CBD effects and cannabinoids in cats isn't relevant here, but the user did mention needing state-specific info if available. While the RAG doesn't cover regulatory details, I know that many US and Canadian jurisdictions have general per-serving THC limits, commonly around 10 mg per serving for adult-use, and some medical states allow higher limits.**Explaining dosage specifics** I see that for cannabis edibles, some jurisdictions allow microdose pieces as low as 2.5 or 5 mg. Others may have requirements for dosage homogeneity and variance tolerances. For CBD-only products, they usually don’t have a per-piece THC requirement but instead mandate that THC content must be limited to either 0.3% or 1 mg THC per serving in hemp products. I want to make sure these details are clear and relevant for the user’s question!**Summarizing dosage regulations** I need to produce a concise summary regarding the cannabis industry's per-piece dosage requirements for edibles. The user wants to understand the max dosage regulations, including state-specific information if available. While the RAG context includes details on unrelated CBD uses, I’ll focus on general regulatory patterns in the U.S. and Canada, where many areas set limits of 10 mg THC per serving and 100 mg per package for adult use, with..."
    },
    {
      "questionNum": 18,
      "question": "What am I allowed to cut my vape cartridge APIs (distillate or decarbed resin) with that is safe and compliant?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "### Quick‑Reference: Common, Regulatory‑Friendly Dilution Agents for Vape‑Cartridge APIs  \n\n| Agent | Typical Use in Cartridges | Inhalation Safety Status | Typical % Maximum (per state guidance) | Key Compliance Notes |\n|-------|---------------------------|--------------------------|----------------------------------------|----------------------|\n| **Food‑grade terpenes (cannabis‑derived or botanical)** | Flavor & viscosity boost; primary “cut” for distillate or decarbed resin | GRAS for inhalation when used at low concentrations; widely accepted by state regulators | 5‑15 % of total cartridge volume (some states cap at 10 %) | Must be pure, solvent‑free, and sourced from a licensed terpene supplier. Keep a Certificate of Analysis (CoA). |\n| **Medium‑Chain Triglyceride (MCT) oil (C8/C10)** | Viscosity reducer for high‑THC distillates; provides a neutral carrier | Generally recognized as safe for oral use; inhalation data are limited but many states allow it as a “cannabis‑derived oil” diluent | 5‑20 % (often ≤10 % for inhalable products) | Must be 100 % plant‑derived, no additives, and have a clean‑room grade (pharmaceutical/USP). |\n| **Propylene Glycol (PG)** | Traditional e‑liquid base; reduces viscosity, adds throat hit | FDA‑GRAS for oral/inhalation in nicotine e‑liquids; accepted in several cannabis‑vape markets | 5‑15 % (some states prohibit PG in THC cartridges) | Verify that your state’s cannabis‑specific regulations allow PG. Keep a USP‑grade CoA. |\n| **Vegetable Glycerin (VG)** | Thickens liquid, adds smooth vapor | FDA‑GRAS for oral/inhalation; accepted in many states for THC cartridges | 5‑15 % (often used with PG) | Same caveat as PG – check state‑specific listings. |\n| **Cannabis‑derived “dilution oil” (e.g., high‑CBD oil, low‑THC distillate)** | Provides cannabinoid balance while thinning | Same safety profile as the source cannabis oil | Varies; usually limited to 10‑20 % of total volume | Must be fully tested and labeled as a cannabis‑derived ingredient. |\n\n---\n\n## How to Ensure Safety & Compliance\n\n1. **Check Your State’s Approved‑Additive List**  \n   - Most states publish a **“Certified Additives”** or **“Approved Dilutants”** list (e.g., Washington RCW 69.50.020, Oregon ORS 735‑830‑030).  \n   - Verify that the exact product (brand, batch, purity) appears on that list.  \n\n2. **Use Only GRAS‑Qualified, Pharmaceutical‑Grade Materials**  \n   - Look for **USP**, **FCC**, or **Food‑Grade** certifications.  \n   - Keep\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1178 (178?1000) | Cost: $0.000000*",
      "duration": 11370,
      "grade": "F",
      "score": 34,
      "grading": {
        "accuracy": 6,
        "completeness": 6,
        "relevance": 12,
        "clarity_structure": 7,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly attempts to list potential diluents and their purposes",
        "Encourages obtaining Certificates of Analysis and using higher-grade materials",
        "Mentions cannabis-derived oils as a compliant thinning option in some markets"
      ],
      "weaknesses": [
        "Incorrectly states terpenes, PG, and VG are GRAS for inhalation; GRAS does not apply to inhalation safety",
        "Misrepresents regulatory landscape by implying most states have approved additive lists and cites inaccurate statutes",
        "Suggests MCT, PG, and VG are widely allowed; many states restrict or prohibit these in inhalable cannabis products",
        "Omits critical bans like vitamin E acetate and concerns with PEG/PEG400",
        "Fails to emphasize that some jurisdictions only allow cannabis-derived constituents in vapes",
        "Lacks discussion of required compliance testing (heavy metals, residual solvents, pesticides) and labeling",
        "Provides arbitrary percentage ranges without state-specific backing",
        "Answer is truncated and incomplete"
      ],
      "feedback": "The answer is on-topic but contains significant inaccuracies and omissions. Replace claims that ingredients are GRAS for inhalation—GRAS pertains to ingestion, not inhalation. Explicitly note bans on vitamin E acetate and restrictions on PG, VG, PEG, and MCT that vary by state; in some markets only cannabis-derived constituents are permitted. Provide correct regulatory references and avoid generic percentage ranges without state citations. Add guidance on required testing (residual solvents, heavy metals, pesticides), ingredient disclosure, and sourcing terpenes with verified purity. Clarify that inhalation safety data are limited and compliance must be state-specific.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "commission",
        "sop",
        "standard",
        "record",
        "test",
        "coa",
        "certificate",
        "analysis"
      ],
      "expectedAnswer": "**Summarizing vape cartridge compliance** I need to summarize the expected answer to the cannabis industry question about safe and compliant cutting agents for vape cartridges. The relevant knowledge base includes general cannabis compliance and formulation ingredient safety. There are restrictions on cutting agents, such as no vitamin E acetate and limitations on PG, PEG, or MCT in some states. We should also highlight that only cannabis-derived constituents may be allowed, with testing for heavy metals, residual solvents, and pesticides needing to be addressed.I'm considering the importance of temperature stability and viscosity in vape formulations while avoiding unknown diluents. It seems using food-grade terpenes or those recognized as GRAS (Generally Recognized as Safe) by FEMA might be an option. However, I've realized that just because something is GRAS for oral consumption doesn't guarantee inhalation safety. It's crucial to ensure any ingredients used are truly safe for inhalation. This aspect needs careful attention to prioritize user safety!**Evaluating safety and stability** I’m thinking about temperature stability and viscosity while avoiding unknown diluents. Should I consider food-grade terpenes that are GRAS (Generally Recognized as Safe) by FEMA? But I realize that inhalation safety can’t be guaranteed by GRAS, as it primarily applies to oral consumption. So, I need to be cautious about this choice. I’ll weigh the importance of both stability and safety in m..."
    },
    {
      "questionNum": 19,
      "question": "What are considered banned substances when formulating various cannabis products?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "Below is a practical overview of **substances that are commonly prohibited (or tightly limited) in cannabis‑derived products** in the United States, Canada, and the European Union.  The exact list varies by jurisdiction, but the categories and examples below cover the vast majority of “banned” ingredients that a formulators should watch for.\n\n| **Category** | **Typical Banned / Restricted Substances** | **Why It’s Banned / Limited** | **Regulatory References** |\n|--------------|--------------------------------------------|------------------------------|----------------------------|\n| **Pesticides & Agricultural Chemicals** | • Any EPA‑registered pesticide not on the “allowed list” for cannabis (e.g., organophosphates, carbamates, pyrethroids, neonicotinoids)<br>• Fungicides such as chlorothalonil, captan, benomyl<br>• Herbicides like glyphosate, paraquat | Residues can be toxic, cause chronic health effects, or exceed permissible limits. | U.S. EPA (via state cannabis‑specific pesticide lists), Health Canada Pesticide Residue Limits (PRLs), EU Pesticide Residue Regulations (EU 2020/1169). |\n| **Heavy Metals & Minerals** | • Lead (Pb), arsenic (As), cadmium (Cd), mercury (Hg), chromium (Cr), nickel (Ni) – any amount above the state‑defined limits (often µg/g). | Cumulative toxicity, especially for oral products. | USP <231> (Cannabis), Health Canada (Heavy‑Metal Limits), EU (Commission Regulation (EU) 2021/1129). |\n| **Residual Solvents** | • Benzene, chloroform, carbon tetrachloride, methylene chloride, 1,1‑dichloroethane, etc.<br>• Solvents that exceed pharmacopeial limits (e.g., > 500 ppm for ethanol is usually acceptable; > 10 ppm for toluene is not). | Solvents are carcinogenic or neurotoxic; limits protect consumer safety. | USP <467> (Residual Solvents), Health Canada (Solvent Limits), EU (Guideline on Residual Solvents). |\n| **Synthetic Cannabinoids & Non‑Cannabis Actives** | • JWH‑018, AB‑CHMINACA, XLR‑11, etc.<br>• Any “designer drug” not derived from the cannabis plant. | They are not approved for human consumption and have unknown safety profiles. | U.S. DEA Controlled Substances Act, Health Canada Controlled Drugs and Substances Act, EU Narcotics Directive. |\n| **Vitamin E Acetate** | • Pure vitamin E acetate added as a diluent or thickener (particularly in vape liquids). | Linked to the 2019 “EVALI” lung injury outbreak. | FDA warning letters (2019‑2020), Health Canada (vape product guidance). |\n| **Diacetyl & Related Flavorings** | • Diacetyl, 2,3‑pentanedione, acetoin (often used for buttery flavor). | Inhalation can cause bronchiolitis obliterans (“popcorn lung”). | FDA (GRAS status limited to food, not inhalation), Health Canada (vape flavouring guidelines). |\n| **Excessive Sweeteners / Sugar Alcohols** | • High‑level sorbitol, mannitol, xylitol in edibles that exceed toxic thresholds for children/pets. | Can cause GI distress or hypoglycemia in pets. | FDA Food Code, Health Canada Food Safety. |\n| **Non‑Food‑Grade Excipients in Edibles** | • Propylene glycol (PG) > 50 % w/w in oral products (PG is permitted in inhalables but not in foods unless\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1163 (163?1000) | Cost: $0.000000*",
      "duration": 11638,
      "grade": "F",
      "score": 51,
      "grading": {
        "accuracy": 13,
        "completeness": 10,
        "relevance": 15,
        "clarity_structure": 8,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Covers major banned/restricted categories such as pesticides, heavy metals, residual solvents, synthetic cannabinoids, and vitamin E acetate",
        "Flags diacetyl and related diketones as problematic for inhalables",
        "Attempts to provide regulatory references and rationale for restrictions"
      ],
      "weaknesses": [
        "Incorrect residual solvent limits (e.g., ethanol listed as 500 ppm instead of ~5000 ppm per ICH/USP; toluene example is inaccurate)",
        "Mis-cites standards (e.g., USP <231> is obsolete for elemental impurities; cannabis programs typically align to USP <232>/<233> and <467>)",
        "Omits key banned items noted in expectations: nicotine, caffeine, and alcohol (co-formulation), as well as child-appealing flavors and packaging considerations",
        "Does not address mycotoxins or microbial toxins, which are commonly regulated with action limits",
        "Lacks state-specific compliance nuances (e.g., CA, CO, MA, WA) and action thresholds central to the question",
        "Speculative/misleading examples (e.g., PG >50% in edibles) and inclusion of sugar alcohols as generally banned is not supported by cannabis regulations",
        "Truncated/incomplete table reduces clarity and completeness"
      ],
      "feedback": "While the answer identifies several relevant banned/restricted categories (e.g., vitamin E acetate, synthetic cannabinoids, pesticides, heavy metals), it contains notable inaccuracies and gaps. Correct the solvent limits using USP <467>/ICH Q3C (e.g., ethanol ~5000 ppm, toluene ~890 ppm) and reference USP <232>/<233> for elemental impurities. Add key prohibited co-ingredients (nicotine, caffeine, alcohol), child-appealing flavor restrictions, mycotoxins, and common cutting agents for inhalables (e.g., PEG, MCT in some states). Provide state-specific guidance (e.g., California, Colorado, Massachusetts, Washington) and explicit action limits where applicable. Remove unsupported claims (e.g., PG thresholds in edibles, sugar alcohols generally banned) and complete the content for clarity.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "state",
        "federal",
        "fda",
        "board",
        "standard",
        "log",
        "lab",
        "contaminant",
        "pesticide",
        "microbial",
        "mycotoxin",
        "heavy metal",
        "control",
        "edible"
      ],
      "expectedAnswer": "**Summarizing banned substances** I need to create a summary about banned substances in cannabis product formulation, like what agents are restricted for compliance. I should emphasize key requirements and regulations, including specifics for various US states. While I have some context about CBD and its effects, I need to stick to general cannabis regulations. Common banned substances include adulterants, synthetic cannabinoids, vitamin E acetate for inhalables, and potentially cutting agents like PEG. Some flavorings, especially child-appealing aspects, are also restricted.**Clarifying banned ingredients** I need to outline certain banned substances in cannabis product formulation, particularly those that exceed action thresholds. This includes harmful pesticides, mycotoxins, heavy metals, and residual solvents above acceptable limits. Additionally, some ingredients are strictly prohibited, such as nicotine, caffeine, and alcohol in formulations, except for specific beverage categories. However, it's important to note that THC-infused drinks typically cannot include alcohol. So, I’ll specify these key points clearly.**Summarizing banned substances in cannabis products** I need to create a summary about banned substances in cannabis product formulation, specifically focusing on compliance requirements. It's essential to include key regulatory details, particularly U.S. state specifics. In general, many states prohibit adulterants, synthetic cannabinoids, and products like vi..."
    },
    {
      "questionNum": 20,
      "question": "Can I use hemp-based cannabinoids like CBD or CBG (or others) in production of my cannabis products?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "formulation",
      "agentMatch": true,
      "response": "**Short answer:** Yes – you can incorporate hemp‑derived cannabinoids (CBD, CBG, CBC, Δ⁸‑THC, etc.) into cannabis‑style products, provided you stay within the legal limits for Δ⁹‑THC (≤0.3 % dry weight in the U.S.) and meet any applicable labeling, testing, and manufacturing requirements.\n\nBelow is a quick‑reference checklist that covers the key points you’ll need to address when formulating with hemp‑derived actives.\n\n---\n\n## 1. Regulatory Baseline (U.S. focus, similar concepts apply in most jurisdictions)\n\n| Requirement | What to check | Typical threshold |\n|-------------|---------------|-------------------|\n| **Δ⁹‑THC content** | COA of the hemp extract must show ≤0.3 % Δ⁹‑THC (dry weight) | ≤0.3 % |\n| **Source legality** | Certified Industrial Hemp (USDA‑approved or state‑licensed) | N/A |\n| **Labeling** | Must disclose total cannabinoids, source (hemp‑derived), and any health claims must be FDA‑compliant | N/A |\n| **Product category** | Food, supplement, topical, or inhalable – each has its own set of rules (e.g., GRAS status for edibles, FDA NDA for inhalables) | N/A |\n| **State variations** | Some states cap total THC at 0.5 % or have additional licensing | Check local board |\n\n**Bottom line:** As long as the final product’s Δ⁹‑THC stays ≤0.3 % and you have a current COA for every batch of hemp extract, you’re compliant for most federal purposes. State‐specific rules may be stricter.\n\n---\n\n## 2. Formulation Considerations\n\n| Aspect | Hemp‑derived vs. flower‑derived | Practical tip |\n|--------|--------------------------------|---------------|\n| **Purity & profile** | Hemp extracts often contain high CBD/CBG and low THC; may also carry residual solvents or lipids | Use a COA to confirm cannabinoid percentages, residual solvent limits, pesticide screens |\n| **Solubility** | CBD & CBG are lipophilic; need carriers (MCT oil, PEG‑400, ethanol) for liquids or nano‑emulsions for water‑based products | Choose a delivery system that matches your end‑product (e.g., nano‑emulsion for beverages) |\n| **Stability** | Oxidation of cannabinoids can produce CBN; terpene loss is common | Add antioxidants (vitamin E, rosemary extract) and store in amber, nitrogen‑flushed containers |\n| **Taste & odor** | Hemp extracts can be earthy/grass‑like | Mask with flavorings (natural terpenes, fruit extracts) or use deodorization steps (vacuum stripping) |\n| **Dosing precision** | Concentrated isolates (≥99 % CBD) give tight dose control; broad‑spectrum extracts have variable ratios | For medical‑grade products, consider isolates or well‑characterized broad‑spectrum batches |\n\n---\n\n## 3. Common Product Types & Typical Use Levels\n\n| Product | Typical hemp‑cannabinoid range* | Example dosage |\n|---------|-------------------------------|----------------|\n| **Edibles (gummies, chocolates)** | 5–25 mg CBD per serving; 0.5–5 mg CBG | 20 mg CBD gummy |\n| **Tinctures / softgels** | 10–50 mg CBD per 30 mL (tincture) or per capsule | 30 mg CBD softgel |\n| **Topicals (creams, balms)** | 0.5–5 % total cannabinoids (by weight) | 2 % CBD cream |\n| **Vape oils** | 5–15 % total cannabinoids (must stay below 0.3 % Δ⁹‑THC) | 10 % CBD vape |\n| **Pet products** | 1–5 mg CBD per 5 lb body weight per day | 5 mg CBD chew for a 30 lb dog |\n\n\\*Ranges assume a hemp‑derived source; adjust upward if you’re blending with flower‑derived material\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1215 (215?1000) | Cost: $0.000000*",
      "duration": 7387,
      "grade": "F",
      "score": 48,
      "grading": {
        "accuracy": 10,
        "completeness": 8,
        "relevance": 12,
        "clarity_structure": 13,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, organized structure with actionable formulation tips (solubility, stability, dosing)",
        "Emphasizes COAs, testing, and some state-by-state variability",
        "Provides practical product-type ranges and considerations for manufacturing"
      ],
      "weaknesses": [
        "Misstates compliance baseline by implying hemp THC ≤0.3% ensures general compliance; this ignores that most state marijuana programs prohibit hemp-derived cannabinoids in regulated cannabis products",
        "Fails to distinguish clearly between federal hemp law and state-regulated marijuana program requirements (track-and-trace, in-state sourcing, licensees)",
        "Omits critical issues: total THC calculations, prohibitions on synthetic conversions (e.g., CBD-to-delta-8), and bans on certain hemp-derived intoxicants in many states",
        "Incorrect or misleading FDA statements (CBD is not approved/GRAS for use in conventional foods or dietary supplements; inhalables are not subject to FDA NDA in this context)",
        "Suggests Δ8-THC can be used broadly despite widespread state restrictions or bans",
        "Does not address that marijuana-market products often must source cannabinoids from licensed cannabis within the regulated system"
      ],
      "feedback": "While the answer is well-structured and offers useful formulation pointers, it is misleading on compliance. In regulated cannabis markets, many states prohibit using hemp-derived cannabinoids in marijuana products and require sourcing from licensed, in-state cannabis with track-and-trace. The 0.3% Δ9-THC threshold applies to hemp definition, not to marijuana program compliance. The answer also omits total THC calculations and conversion prohibitions (e.g., CBD-to-Δ8) and includes inaccurate FDA references. Refocus on federal vs state distinctions, state marijuana program rules, total THC, and synthetic conversion bans to provide correct, practical guidance.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "must",
        "state",
        "federal",
        "fda",
        "sop",
        "procedure",
        "standard",
        "operating",
        "testing",
        "test",
        "coa",
        "certificate",
        "analysis"
      ],
      "expectedAnswer": "**Analyzing cannabinoid compliance** I need to create a grading summary addressing whether hemp-based cannabinoids like CBD or CBG can be used in cannabis product formulation. This is particularly relevant in the context of compliance and regulations, as many states have restrictions on “hemp-derived cannabinoids” in the marijuana market. I'll reference insights from three PubMed articles related to CBD and its implications. Additionally, I'll ensure to cover vital compliance pointers and address issues like “Total THC” calculations and synthetic conversion prohibitions to provide thorough guidance.**Clarifying federal versus state regulations** I should note that federal law, specifically the 2018 Farm Bill, defines hemp as cannabis containing less than 0.3% delta-9 THC. However, state cannabis programs frequently have stricter requirements, insisting that all cannabinoids must come from marijuana plants grown within regulated systems. This distinction is crucial for anyone looking to navigate the compliance landscape surrounding the use of hemp-derived cannabinoids in cannabis products. It's an important aspect to clarify for the user’s understanding.**Producing a grading summary** I need to create a grading summary for a question about using hemp-based cannabinoids like CBD or CBG in cannabis product production. I’ve got context from three PubMed articles, which is useful. The main focus is on compliance and regulatory aspects, which is very relevant currently due to restr..."
    },
    {
      "questionNum": 21,
      "question": "Can I store finished products in the same room as raw biomass?",
      "category": "facility-setup-operational-procedures",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most licensed cannabis operations you **should not** store finished products in the same room as raw biomass. Separate, dedicated storage spaces are required (or strongly recommended) to meet regulatory, quality‑control, and security standards.\n\n---\n\n### Why separation is required\n\n| Reason | What it means for storage |\n|--------|---------------------------|\n| **Regulatory compliance** | State/provincial cannabis regulations (e.g., California BCC, Colorado MCR, Ontario OCS) typically mandate *segregated* storage for “raw material” vs. “finished product.” Mixing them can trigger a compliance violation and possible license action. |\n| **Cross‑contamination risk** | Raw biomass can shed pollen, mold spores, pests, and residual solvents that can degrade potency, flavor, and safety of the finished product. |\n| **Product integrity** | Finished goods (edibles, concentrates, flower) often require tighter temperature/humidity control (e.g., 60‑65 °F / 55‑62 % RH for flower) than raw material, which can be stored at slightly broader ranges. |\n| **Security & inventory tracking** | Finished product is a higher‑value, higher‑risk inventory item. Separate rooms simplify access control, video monitoring, and inventory reconciliation (e.g., using METRC, BioTrackTHC, etc.). |\n| **Odor & pest management** | Raw plant material can emit strong odors and attract pests; keeping it apart helps maintain a clean, odor‑controlled environment for finished goods. |\n| **Audit ease** | Inspectors can quickly verify that you are following “first‑in‑first‑out” (FIFO) and “track‑and‑trace” procedures when storage areas are clearly delineated. |\n\n---\n\n### Typical best‑practice layout\n\n1. **Raw Biomass Room**  \n   - Bulk receiving, drying/curing, and primary grinding.  \n   - Separate ventilation, HEPA filtration, and pest‑control measures.  \n\n2. **Intermediate Processing Area**  \n   - Extraction, infusion, or trimming stations.  \n   - Often a “cleanroom” or controlled‑environment zone.  \n\n3. **Finished‑Product Storage**  \n   - Climate‑controlled, locked room or refrigerated unit.  \n   - Separate from any raw plant material.  \n   - Clearly labeled zones for each product type (edibles, vape cartridges, flower, etc.).  \n\n4. **Quarantine/Quality‑Control Zone**  \n   - For items awaiting testing or release.  \n   - Physically isolated from both raw and finished product storage.\n\n---\n\n### Minimum compliance checklist (U.S.‑style)\n\n- **Physical separation** – at least one door and distinct walls/partitions; not merely a “different shelf.”  \n- **Access control** – key‑card or biometric restrictions for finished‑product area only.  \n- **Environmental controls** – temperature/humidity logs meeting product‑specific specs.  \n- **Inventory segregation** – separate lot numbers, barcode/QR‑code tracking for raw vs. finished.  \n- **Cleaning SOPs** – documented cleaning schedule that prevents cross‑contamination when personnel move between zones.  \n- **Documentation** – storage‑area diagrams on file, updated whenever layout changes.\n\n*(If your jurisdiction has a different set of rules, the same principles usually apply; you can confirm the exact wording in your state’s cannabis licensing handbook.)*\n\n---\n\n### What to do next\n\n1. **Review your local licensing regulations** – locate the “storage” or “inventory control” section.  \n2. **Audit your current layout** – ensure raw biomass and finished product are in separate, locked rooms.  \n3. **Implement SOPs** – create or update standard operating procedures covering segregation, access, and environmental monitoring.  \n4. **Consider a\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1164 (164?1000) | Cost: $0.000000*",
      "duration": 9818,
      "grade": "D",
      "score": 63,
      "grading": {
        "accuracy": 16,
        "completeness": 12,
        "relevance": 13,
        "clarity_structure": 14,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, well-organized structure with actionable best-practice recommendations",
        "Addresses key risks like cross-contamination, security, and environmental controls",
        "Includes practical elements such as quarantine zones and SOPs"
      ],
      "weaknesses": [
        "Does not address New York-specific regulations or cite NYS OCM requirements as expected",
        "Overstates a blanket prohibition by implying separate rooms are required in most jurisdictions",
        "Misses the nuance that co-storage may be permissible with physical separation, labeling, and quarantine",
        "References non-NY regulators/entities (e.g., OCS) and includes potentially misleading generalizations",
        "Omits explicit points about finished goods quarantine and labeling specific to NY and the cannabis vs. hemp distinction",
        "Answer is truncated and includes extraneous agent metadata"
      ],
      "feedback": "Good operational guidance and clear structure, but it fails to summarize New York’s OCM rules as requested and overgeneralizes a prohibition on co-storage. To meet expectations, focus on NY-specific requirements: note that co-storage may be allowed if there’s physical separation, secure and sanitary storage, proper labeling, environmental controls, and quarantine for products awaiting testing. Cite or align with NY OCM guidance, clarify that raw biomass refers to cannabis (not hemp), and avoid blanket statements not supported by NY regulations.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "state",
        "epa",
        "sop",
        "procedure",
        "standard",
        "operating",
        "documentation",
        "document",
        "record",
        "testing"
      ],
      "expectedAnswer": "**Summarizing NY cannabis regulations** I need to create a summary about New York cannabis regulations, focusing on whether finished products can be stored in the same room as raw biomass. The key points will include the conclusion and critical regulatory details from the NYS Office of Cannabis Management. There are requirements for separating cannabis products to avoid contamination, including secure storage, environmental controls, and sanitation measures. Finished products awaiting testing must be quarantined and clearly labeled to ensure safety and compliance. It's important to specify that raw biomass refers to cannabis, not just hemp.It seems storing finished cannabis products in the same room as raw biomass may be allowed, but there are conditions. I need to ensure there's physical separation, proper labeling, and environmental controls to prevent cross-contamination and odors. However, most regulators prefer keeping finished products in separate rooms or distinct areas for added safety. It's important to follow best practices to maintain compliance and ensure the integrity of the products being stored.**Summarizing NY cannabis regulations** I need to create a summary about New York cannabis regulations regarding storing finished products with raw biomass. The main points should include key requirements like the segregation of products to avoid contamination and cross-contact, with a focus on regulations from the NYS Office of Cannabis Management. It’s important to men..."
    },
    {
      "questionNum": 22,
      "question": "Do I need to log the cleaning of the extraction booth before starting the next run?",
      "category": "facility-setup-operational-procedures",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Yes – you should log the cleaning of the extraction booth before every new run.**  \n\n| Reason | What to record | Typical format |\n|--------|----------------|----------------|\n| **Regulatory compliance** (state cannabis‑board, GMP, ISO‑22716, FDA‑type guidance) | Date, time, booth ID, cleaning agent(s), concentration, contact time, rinse/de‑contam steps | Log sheet or electronic LIMS entry |\n| **Product safety & consistency** | Who performed the cleaning, certification (e.g., “cleanroom‑qualified”), any deviations or failures | Signature / initials, employee ID |\n| **Traceability** | Batch/lot number of the upcoming extraction, equipment calibration status | Link cleaning entry to the batch record |\n| **Audit readiness** | Quick visual confirmation that the booth met “clean” criteria (e.g., swab test results, visual inspection checklist) | Check‑box + optional swab result value (ppm) |\n| **Continuous improvement** | Frequency of cleaning, any issues (residue, spills) that required extra steps | Comments field |\n\n### Minimal “clean‑booth” entry (paper or electronic)\n\n1. **Date & Time** – when cleaning completed.  \n2. **Operator** – name & ID (signature if paper).  \n3. **Cleaning agent** – product name, dilution ratio, lot #.  \n4. **Procedure** – “Wipe‑down of interior surfaces, floor, and door seals; 10 min dwell; water rinse; air‑dry.”  \n5. **Verification** – visual inspection ✅; optional swab test result (e.g., < 5 ppm total residues).  \n6. **Batch linked** – extraction batch # XXXX.  \n7. **Comments** – any deviations, spills, or need for repeat cleaning.\n\n### Why it matters\n\n- **Regulators** (state cannabis boards, USDA, Health Canada, etc.) often require a **cleaning/maintenance log** as part of the batch record. Failure to document can trigger a **non‑conformance** during an audit.\n- **Cross‑contamination** of cannabinoids, solvents, or terpenes can alter potency, flavor, and safety of the next product run.\n- **Traceability** lets you quickly pinpoint the source of an out‑of‑spec result (e.g., residual solvent from a previous batch).\n\n### Quick tip\nIf you use a Laboratory Information Management System (LIMS) or ERP, set up an automatic “clean‑booth” task that must be completed and signed off before the system will allow you to start a new extraction job. This enforces the practice and eliminates missed entries.\n\n**Bottom line:** Log every cleaning event—date, agent, method, verification, and link it to the upcoming batch. It keeps you compliant, protects product quality, and saves headaches during audits.\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 902 (210?692) | Cost: $0.000000*",
      "duration": 11704,
      "grade": "C",
      "score": 78,
      "grading": {
        "accuracy": 24,
        "completeness": 16,
        "relevance": 17,
        "clarity_structure": 13,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly answers yes and explains why logging is needed",
        "Provides a detailed, actionable list of what to record (date/time, agent, contact time, operator, verification, batch link)",
        "Offers a practical minimal entry template and LIMS/ERP enforcement tip",
        "Emphasizes traceability and audit readiness"
      ],
      "weaknesses": [
        "Lacks New York–specific citations (e.g., 9 NYCRR Part 132) required by the expected answer",
        "Does not mention record retention period (at least two years) per NY requirements",
        "Omits explicit supervisor verification/sign-off requirement",
        "References generic or non-NY regulators/standards (USDA, Health Canada, ISO-22716) which may be irrelevant in this context",
        "More verbose than the concise compliance summary requested"
      ],
      "feedback": "Good practical guidance and clear rationale, but to meet the expected standard you should anchor the answer in New York’s regulatory framework. Cite 9 NYCRR Part 132, state that sanitation SOPs/logs are required, include supervisor verification/sign-off, and note the minimum two-year record retention. Trim to a concise compliance summary focused on NY processors.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "required",
        "must",
        "state",
        "california",
        "oregon",
        "massachusetts",
        "board",
        "sop",
        "procedure",
        "standard",
        "document",
        "record"
      ],
      "expectedAnswer": "**Summarizing New York compliance for cleaning** I need to create a concise summary regarding whether to log the cleaning of the extraction booth before starting the next run. New York cannabis regulations specify that sanitation logs and SOPs are required, including maintaining cleaning records for equipment and facilities. I'll mention that cleaning between batches is essential, and records need to include details like who performed the cleaning, the chemicals used, and supervisor verification. It's important to note that records should be retained for at least two years.**Generating compliance summary** I need to create a concise summary addressing whether to log cleaning of the extraction booth before starting a new run, particularly within New York's regulatory context. New York cannabis regulations demand maintaining sanitation SOPs, sanitation logs, and record-keeping of cleaning procedures. This includes documenting details such as who performed the cleaning, the chemicals used, contact times, and certification by a supervisor. It's essential to follow 9 NYCRR Part 132, which outlines these requirements for adult-use processors, ensuring compliance with GMP-like practices."
    },
    {
      "questionNum": 23,
      "question": "Is it okay to perform maintenance on the hydrocarbon extractor during operating hours?",
      "category": "facility-setup-operational-procedures",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nNo – routine or corrective maintenance on a hydrocarbon (e.g., butane, propane) extractor should **never be performed while the unit is in production**. The extractor must be fully shut down, purged, and cleared of hydrocarbons before any work that involves opening panels, removing components, or touching wiring, plumbing, or moving parts.\n\n---\n\n## Why you must stop the extractor first\n\n| Reason | What it means for you |\n|--------|----------------------|\n| **Explosion/Fire Hazard** | Hydrocarbons are highly flammable. Even a tiny residual vapor can ignite from a spark, static discharge, or hot surface. |\n| **Regulatory compliance** | OSHA (1910.119), NFPA 58 (Liquefied Petroleum Gas Code), and most state cannabis‑specific regulations (e.g., California B.C.L. §11362, Colorado DORA) require a “no‑work‑while‑running” policy for hydrocarbon equipment. |\n| **Equipment protection** | Running compressors, pumps, and heaters while you’re removing or tightening bolts can cause premature wear or damage the seals, leading to leaks later. |\n| **Worker safety** | Maintenance often involves tools that can generate sparks (e.g., power drills) or create static. With the system pressurized and full of vapor, the risk of injury skyrockets. |\n| **Documentation** | Most SOPs and batch records require a “system shutdown & purge” signature before any maintenance activity can be logged. |\n\n---\n\n## Minimum safe‑shutdown procedure (typical SOP)\n\n> **Note:** Adapt the steps to your specific extractor model, local regulations, and your written SOPs. The sequence below follows industry best practice.\n\n1. **Stop the extraction cycle** – Finish the current run, close the valve to the extraction vessel, and disengage the pump/compressor.\n2. **Depressurize** – Slowly vent any remaining pressure to a closed‑vent system or scrubber. Verify that pressure gauges read zero.\n3. **Purge the system** – Run a purge cycle with inert gas (e.g., nitrogen) or forced air until the hydrocarbon concentration in the vessel and surrounding area is < 1 % LEL (Lower Explosive Limit). Use an LEL detector to confirm.\n4. **Lock‑out/Tag‑out (LOTO)** – Apply LOTO devices on power, hydraulic, and pneumatic sources. Verify isolation with a “try‑start” test (no motor should turn).\n5. **Ventilation check** – Ensure the extraction room’s exhaust fans are operating and that the air exchange rate meets the manufacturer’s spec (often 12–15 ft³/min per ft² of floor area for hydrocarbon work).\n6. **Atmospheric monitoring** – Use a calibrated combustible gas monitor at the worksite. Readings must be below the alarm threshold (typically < 10 % of LEL) before you touch anything.\n7. **Grounding & static control** – Ground the extractor chassis and any tools you’ll use. Wear anti‑static footwear and a grounding wrist strap if required.\n8. **Perform the maintenance** – Follow the equipment manufacturer’s maintenance checklist (tighten bolts, replace seals, inspect wiring, etc.).\n9. **Post‑maintenance test** – After re‑assembly, conduct a leak check (soap‑bubble, electronic leak detector, or pressure decay test). Verify that all LEL readings remain safe.\n10. **Remove LOTO & restart** – Only after a successful test and a sign‑off from the qualified operator can you restore power and resume extraction.\n\n---\n\n## Common misconceptions\n\n| Misconception | Reality |\n|---------------|---------|\n| “The extractor is sealed, so there’s no vapor outside the vessel.” | Even sealed vessels have bleed lines, valves, and pump connections that can leak. Vapors can accumulate in the enclosure, the vent hood, or even the floor drain. |\n| “We can do quick visual inspections while it runs.” | Visual checks that involve opening panels, removing covers, or moving parts still expose you to potential leaks. Use external cameras or remote monitoring if you need a “live” check. |\n| “Our fire‑suppression system will handle any spark.” | Suppression systems mitigate *after* a fire starts; they do not prevent an explosion. The safest approach is to eliminate the fuel (hydrocarbon)\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1133 (133?1000) | Cost: $0.000000*",
      "duration": 17114,
      "grade": "C",
      "score": 76,
      "grading": {
        "accuracy": 20,
        "completeness": 16,
        "relevance": 18,
        "clarity_structure": 14,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly answers the question: maintenance should not be performed while the extractor is operating",
        "Provides solid safety rationale (fire/explosion hazards, worker safety, equipment protection)",
        "Offers actionable shutdown steps (depressurize, purge, LOTO, leak check, atmospheric monitoring)",
        "Well-organized and easy to follow"
      ],
      "weaknesses": [
        "Lacks New York-specific regulatory context and ICC/IFC references expected by the prompt",
        "Includes questionable/irrelevant citations (e.g., California BCL §11362, Colorado DORA) and overgeneralizes OSHA 1910.119",
        "Ventilation guidance (12–15 cfm/ft²) appears inaccurate for code; IFC typically requires around 1 cfm/ft² continuous ventilation",
        "Inconsistent LEL thresholds (<1% LEL vs <10% LEL) and suggests “forced air” purge, which can be unsafe without proper containment/vent",
        "Not concise relative to the expected summary and omits explicit mention of NFPA/ICC compliance requirements and written SOP mandates"
      ],
      "feedback": "Good, safety-forward answer that correctly states maintenance must not occur while the extractor is operating and provides useful procedural steps. To meet the expected standard, anchor guidance to New York requirements and applicable codes (ICC/IFC as adopted by NYS, NFPA 1/58/70/70E/55), explicitly state the need for written SOPs, shutdown and purge before maintenance, and avoid inaccurate specifics (ventilation rates, mixed LEL criteria, and non-relevant regulatory citations). Use inert gas purging and closed-vent controls consistent with code and manufacturer instructions.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "must",
        "state",
        "california",
        "colorado",
        "osha",
        "epa",
        "agency",
        "sop",
        "procedure",
        "standard",
        "document"
      ],
      "expectedAnswer": "**Summarizing extractor maintenance guidelines** I need to create a concise summary regarding maintenance for cannabis hydrocarbon extractors in New York. This involves outlining key requirements and regulatory details, especially focusing on compliance with the state's regulations on hydrocarbon extraction. It's critical to note that the extraction area must meet NFPA and ICC standards, and maintenance can't occur while operational. Compliance with safety protocols is essential, including written SOPs and ensuring the system is shut down and purged before any maintenance activities."
    },
    {
      "questionNum": 24,
      "question": "Am I allowed to have non-lab staff enter the extraction area if they’re just observing?",
      "category": "facility-setup-operational-procedures",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 264,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "compliance",
      "agentMatch": false
    },
    {
      "questionNum": 25,
      "question": "Do I need to notify regulators before making changes to the lab layout?",
      "category": "facility-setup-operational-procedures",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 80,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "compliance",
      "agentMatch": false
    },
    {
      "questionNum": 26,
      "question": "Can I use ethanol I purchased from a non-cannabis supplier in today’s extraction?",
      "category": "extraction-batch-production-rules",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 308,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "f8_agent",
      "agentMatch": false
    },
    {
      "questionNum": 27,
      "question": "Is it compliant to run two different extraction methods in the same lab on the same day?",
      "category": "extraction-batch-production-rules",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 66,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "f8_agent",
      "agentMatch": false
    },
    {
      "questionNum": 28,
      "question": "Do I need to document the purge time for each batch of concentrate?",
      "category": "extraction-batch-production-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "f8_agent",
      "agentMatch": false,
      "response": "**Short answer:** Yes – you should record the purge time (along with temperature, pressure, and equipment) for every batch of concentrate.  \n\n---\n\n## Why documentation is essential\n\n| Reason | How purge‑time data helps |\n|--------|---------------------------|\n| **Regulatory compliance** | Most state cannabis‑tracking systems (e.g., METRC, BioTrackTHC) and GMP‑style guidelines require a complete batch record that includes all critical process parameters. |\n| **Product consistency** | Purge duration directly influences residual solvent levels, terpene retention, and final potency. Recording it lets you reproduce the exact profile batch‑to‑batch. |\n| **Quality & safety** | You can verify that residual solvent limits (e.g., <10 ppm for butane) are met and quickly identify out‑of‑spec batches. |\n| **Shelf‑life & stability** | Longer purges may reduce volatile terpenes, affecting flavor and oxidation stability. Documentation lets you correlate purge time with later stability data. |\n| **Audit & traceability** | In the event of a recall, inspection, or COA review, the purge log provides a clear link between the raw material, process, and final product. |\n| **Process optimization** | Over time you can analyze trends (e.g., “10 min at 120 °C yields optimal terpene profile”) and adjust SOPs accordingly. |\n\n---\n\n## What to capture for each batch\n\n1. **Batch identifier** (lot number, date, product SKU)  \n2. **Equipment** (vacuum oven, rotary evaporator, short‑path distillation unit, etc.) – include serial number.  \n3. **Purge parameters**  \n   - **Temperature** (set point & actual average)  \n   - **Pressure** (vacuum level, e.g., “‑29 inHg”)  \n   - **Time** ( purge duration; note any staged ramps).  \n4. **Initial solvent load** (e.g., volume of butane added) – useful for mass‑balance checks.  \n5. **Operator name / shift**  \n6. **Any deviations** (e.g., power loss, temperature spikes) and corrective actions.  \n7. **Resulting analytical data** (post‑purge residual solvent COA, potency, terpene profile).  \n\nAll of the above should be entered into your batch‑record system (paper log, LIMS, or METRC‑compatible software) at the time of purge, not retro.\n\n---\n\n## Practical tips for implementation\n\n| Tip | How to apply |\n|-----|--------------|\n| **Standard Operating Procedure (SOP)** | Write an SOP that lists purge‑time documentation as a mandatory step. Include a sample data‑entry table. |\n| **Electronic capture** | Use a tablet or lab‑PC linked to the extraction rig so the operator can start/stop a timer that automatically stamps the record. |\n| **Automated sensors** | If your vacuum oven has built‑in data logging, export the temperature‑/pressure‑vs‑time curve and attach it to the batch file. |\n| **QC checkpoint** | Require a “purge‑clearance” signature from QC before the concentrate moves to packaging. |\n| **Training** | Conduct a brief refresher each quarter to reinforce why purge data matters for compliance and product quality. |\n\n---\n\n## Bottom line\n\n- **Regulators & auditors expect it.**  \n- **Your QA/QC team will rely on it to prove that every concentrate meets residual‑solvent limits and terpene specifications.**  \n- **Future product development benefits from the trend data you’ll generate.**  \n\nTherefore, make purge‑time documentation a non‑negotiable part of every batch record.\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1103 (207?896) | Cost: $0.000000*",
      "duration": 6249,
      "grade": "B",
      "score": 85,
      "grading": {
        "accuracy": 22,
        "completeness": 21,
        "relevance": 19,
        "clarity_structure": 14,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question with a clear yes and specifies what to document (time, temperature, pressure, equipment).",
        "Provides strong rationale (compliance, quality, traceability) and actionable guidance (SOPs, logging, QC sign-offs).",
        "Well-structured and easy to follow with concrete implementation tips."
      ],
      "weaknesses": [
        "Includes an inaccurate example for residual solvent limits (e.g., <10 ppm for butane); typical state action limits are much higher (often around 5,000 ppm).",
        "Conflates tracking systems (METRC/BioTrack) with regulatory recordkeeping requirements; the systems don’t themselves require detailed purge parameters.",
        "Does not cite specific state examples (e.g., Colorado MED) or emphasize state-by-state variability as noted in the expected answer.",
        "Longer than necessary for the prompt’s expected concise summary."
      ],
      "feedback": "Good, actionable answer that clearly states purge time must be documented and explains how to do it. Correct the residual solvent limit example (e.g., butane often around 5,000 ppm depending on state) and clarify that detailed batch records are required by state regulations, not the tracking systems themselves. Consider briefly citing a specific state (e.g., Colorado MED) and noting that requirements vary by jurisdiction for tighter alignment with expected content and to keep it concise.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "massachusetts",
        "sop",
        "standard",
        "documentation",
        "document"
      ],
      "expectedAnswer": "**Summarizing documentation requirements** I need to craft a concise summary about whether documenting purge time for each concentrate batch is necessary in the cannabis industry. This involves understanding regulatory requirements around extraction and concentrate production. Purge time is crucial for removing solvents, and most state regulations demand detailed batch records, including parameters like extraction methods, solvent use, temperatures, and more. Specific guidelines vary by state, such as Colorado's MED rules, which require meticulous record-keeping for each batch.**Summarizing documentation requirements** I need to craft a 100-200 word summary responding to the question about documenting purge times for each batch of concentrate in the cannabis industry. Purge time is essential for removing residual solvents during production, and most regulations require thorough documentation of parameters like extraction methods, solvent use, and processing times. Specific state regulations, such as those in Colorado, mandate detailed records, including extraction methods and solvent testing results. It’s crucial to adhere to these requirements for compliance."
    },
    {
      "questionNum": 29,
      "question": "Am I allowed to blend two different strain inputs into a single extraction batch?",
      "category": "extraction-batch-production-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "f8_agent",
      "agentMatch": false,
      "response": "**Short answer:** Yes – you can blend two (or more) distinct cannabis strains in a single extraction batch, provided you follow good manufacturing practices (GMP), maintain full traceability, and meet any state‑ or country‑specific regulatory requirements.\n\n---\n\n## 1. Why blending is common\n| Benefit | How it helps |\n|---------|--------------|\n| **Broader cannabinoid/terpene spectrum** | Combines the strengths of each genotype (e.g., high‑THC + high‑CBD, or complementary terpene profiles). |\n| **Cost efficiency** | Allows you to use a lower‑cost strain to “top‑up” a premium one while still hitting target potency. |\n| **Product differentiation** | Creates unique flavor/aroma or therapeutic synergies that can be marketed as a “hybrid blend.” |\n\n---\n\n## 2. Regulatory & Compliance Checklist\n\n| Item | What to do | Why it matters |\n|------|------------|----------------|\n| **License scope** | Verify that your cultivation/processing license permits mixing genotypes. Some jurisdictions restrict “single‑strain” products for certain medical categories. | Avoid fines or product recalls. |\n| **Batch record integrity** | Document each input strain (lot #, weight, potency, terpene profile, COA) and the exact proportion blended. | Enables traceability and root‑cause analysis. |\n| **Labeling** | The final product label must disclose the presence of multiple strains (or at least the combined cannabinoid/terpene profile). | Consumer transparency; compliance with 21 CFR § 101 (US) or equivalent. |\n| **Testing** | Submit a post‑blend sample for full panel analysis (THC, CBD, minor cannabinoids, terpene profile, residual solvents, pesticides, heavy metals). | Confirms that the final product meets potency and safety specs. |\n| **Allergen/contaminant control** | Ensure neither strain introduces prohibited pesticides, molds, or other contaminants beyond your acceptance limits. | Product safety. |\n| **THC/CBD limits** | Verify that the blended batch still falls within any statutory THC/CBD caps for your product class (e.g., <0.3 % Δ9‑THC for hemp‑derived extracts in the EU/US). | Legal compliance. |\n\n---\n\n## 3. Practical Formulation Considerations\n\n| Consideration | Guidance |\n|---------------|----------|\n| **Proportioning** | Start with a **target potency matrix** (e.g., 18 % THC, 6 % CBD). Use the known %‑potencies of each strain to calculate the weight ratio needed (simple mass‑balance equation). |\n| **Terpene synergy** | If you want a specific aroma or entourage effect, blend strains with complementary terpenes (e.g., myrcene‑rich + limonene‑rich). Run a **GC‑MS** on the blended extract to confirm the final terpene profile. |\n| **Extraction method compatibility** | Ensure both strains behave similarly in your chosen solvent/technique (e.g., supercritical CO₂, ethanol, hydrocarbon). Divergent moisture or lipid content can affect extraction efficiency. |\n| **Homogenization** | After extraction, **mix the combined crude** (or post‑purified controlled temperature (typically 30‑45 °C for CO₂ extracts) to achieve a uniform cannabinoid/terpene distribution. |\n| **Stability** | Conduct a short‑term (30‑day) accelerated stability study on the blended batch to confirm no unexpected degradation (e.g., THC → CBN). |\n| **Batch size** | Keep the total batch within the capacity of your equipment’s **process validation envelope**. If you exceed the validated range, you’ll need to re‑qualify the process. |\n\n---\n\n## 4. Quick “Do‑It‑Yourself” Calculation Example\n\n**Goal:** 100 g final extract, target 15 % THC, 5 % CBD.  \n\n| Strain | Measured potency (per gram of crude) | Desired contribution | Weight needed |\n|--------|--------------------------------------|----------------------|---------------|\n| Strain A (high‑THC) | 20 % THC, 1 % CBD | 12 %\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1208 (208?1000) | Cost: $0.000000*",
      "duration": 7075,
      "grade": "D",
      "score": 61,
      "grading": {
        "accuracy": 18,
        "completeness": 14,
        "relevance": 13,
        "clarity_structure": 9,
        "practical_value": 7,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Acknowledges that blending depends on jurisdictional rules and requires traceability",
        "Covers documentation of inputs (lot numbers, weights, COAs) and post-blend testing",
        "Provides practical considerations for formulation and homogenization"
      ],
      "weaknesses": [
        "Does not mention seed-to-sale tracking specifics or assigning a new batch UID",
        "Omits key constraints like same product type/category/licensee and prohibitions on co-mingling before required testing",
        "Overstates labeling requirements and cites 21 CFR 101, which is not the governing framework for state cannabis labeling",
        "Includes extraneous content (EU/US hemp THC caps, marketing benefits) and is far longer than the requested concise summary",
        "Fails to note homogeneity testing requirements that some states impose; potency labeling guidance not tied to final batch testing",
        "Formatting issues and a truncated example reduce clarity"
      ],
      "feedback": "Provide a concise (100–200 words) summary focused on regulatory essentials: blending may be allowed depending on state rules, but you must maintain seed-to-sale traceability, record each source lot ID and proportions, keep inputs within the same product type/category/licensee, and assign a new batch UID. Emphasize that potency labeling must reflect the final blended batch, and many states require post-process testing (and sometimes homogeneity testing). Note that some jurisdictions prohibit co-mingling prior to required lot testing. Remove non-applicable references (e.g., 21 CFR 101, EU hemp limits) and avoid extraneous marketing/formulation content.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "must",
        "state",
        "epa",
        "sop",
        "standard",
        "documentation",
        "document",
        "record",
        "testing",
        "test",
        "coa",
        "lab",
        "potency"
      ],
      "expectedAnswer": "**Summarizing cannabis extraction rules** I need to create a summary for the user about whether it's allowed to blend two different strain inputs into a single extraction batch. The response should be concise, around 100-200 words, focusing on the general rule. Blending may be allowed, but it depends on state regulations, and it's essential to ensure traceability through the seed-to-sale system. Key requirements include using the same product type, category, and licensee, tracking each source lot ID, and assigning a new batch UID.**Understanding potency labeling requirements** I need to focus on potency labeling, which must accurately reflect the final batch. Some states have specific requirements for post-processing testing, especially for blended batches. Additionally, certain states may require a homogeneity test and might prohibit co-mingling of different inputs before mandatory testing. This means that blending should only occur after these tests have been passed, ensuring the quality and safety of the product. I’ll keep these regulations in mind!**Summarizing cannabis extraction rules** I need to summarize a question about blending different strain inputs into a single extraction batch. The user wants a concise summary of 100-200 words including key points like general rules and critical regulatory details. It seems blending might be permissible depending on state regulations. It's important to ensure traceability in the seed-to-sale system. Requirements include similar..."
    },
    {
      "questionNum": 30,
      "question": "Do I need to label intermediary oils before refinement is complete?",
      "category": "extraction-batch-production-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "f8_agent",
      "agentMatch": false,
      "response": "**Short answer:** Yes – any container that leaves the extraction/processing area (even if it’s only an “intermediate” oil) must be labeled in accordance with the applicable state‑ or country‑specific cannabis‑handling regulations. If the oil stays strictly inside the lab and is never shipped or moved to a packaging line, a simplified internal label is usually acceptable, but it still needs to contain enough information for traceability, safety, and future QC.\n\n---\n\n## Why the label matters\n\n| Reason | What it looks like on an intermediate oil |\n|--------|--------------------------------------------|\n| **Regulatory compliance** | Most jurisdictions (CO, CA, MA, ON, EU, etc.) require *every* container that could be transferred, stored, or transported to be labeled with product identity, potency, batch/lot, and warning statements. |\n| **Traceability & recall readiness** | Batch/lot number, production date, and cannabinoid profile let you pull the exact lot if a problem arises later. |\n| **Safety & handling** | Hazard symbols, storage temperature, and “Not for consumer use” warnings protect workers and prevent accidental dispensing. |\n| **Quality‑control documentation** | Labels tie the physical container to the lab results (COA) and SOPs, making audits straightforward. |\n\n---\n\n## Minimum information you should include (even for a temporary label)\n\n| Item | Typical wording / format |\n|------|---------------------------|\n| **Product identifier** | “Intermediate Cannabis Oil – Extraction #1234” |\n| **Batch / Lot number** | “Lot B‑2025‑10‑31‑01” |\n| **Date of production** | “Produced: 2025‑10‑31” |\n| **Cannabinoid potency (if known)** | “THC ≈ 68 % ± 2 % ; CBD ≈ 0.5 % ± 0.1 %” (use the most recent analytical result) |\n| **Solvent used** | “Solvent: Ethanol (99.9 %)” |\n| **Storage conditions** | “Store ≤ -20 °C, protected from light” |\n| **Safety warnings** | “Flammable – keep away from ignition sources. Not for human consumption.” |\n| **Universal cannabis symbol** (if required by jurisdiction) | ☑︎ (the leaf‑with‑circle) |\n| **Manufacturer / Facility name & license number** | “GreenLeaf Labs, License #CL‑56789” |\n| **“Do not sell” / “Internal use only”** | Prominently displayed |\n\n*Tip:* Use a small, removable “interim” label that can be covered or replaced when the final product label is applied.\n\n---\n\n## How the requirement varies by jurisdiction (quick snapshot)\n\n| Jurisdiction | Must label *all* containers? | Typical label elements required |\n|--------------|------------------------------|---------------------------------|\n| **California (B&C Act)** | Yes – any “intermediate” material that could be transferred out of the extraction area must have a label meeting the same standards as finished product. | Product type, potency, batch, universal symbol, warning statements, license number. |\n| **Colorado** | Yes – “intermediate” extracts are considered “product” for tracking; label must include potency, batch, and “Not for sale” disclaimer. |\n| **Massachusetts** | Yes – all containers must be labeled with cannabinoid content, lot, and a “non‑consumer” statement. |\n| **Ontario (Canada)** | Yes – any “\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1205 (205?1000) | Cost: $0.000000*",
      "duration": 13381,
      "grade": "D",
      "score": 64,
      "grading": {
        "accuracy": 12,
        "completeness": 17,
        "relevance": 18,
        "clarity_structure": 11,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers that intermediate oils should be labeled",
        "Emphasizes traceability, safety, and QC rationale",
        "Provides a practical list of suggested label elements",
        "Notes that simplified internal labels are acceptable for in-lab WIP"
      ],
      "weaknesses": [
        "Incorrectly implies or states that intermediates often need finished-product labeling (e.g., California), which contradicts typical WIP rules",
        "Overstates requirements like universal cannabis symbol, consumer warnings, and potency on WIP containers",
        "Omits key WIP elements such as weight/volume and unique identifier/UID explicitly",
        "Jurisdictional section contains likely inaccuracies and is truncated",
        "Includes extraneous artifact text and incomplete table, reducing clarity"
      ],
      "feedback": "Good emphasis on the need for labeling and traceability, but revise to align with typical cannabis compliance: WIP/intermediate materials generally require internal process labels (UID/lot/batch ID, product name/description, quantity/weight/volume, date, and licensee info) for track-and-trace and chain-of-custody. Final retail labeling (warnings, universal symbol, consumer-facing potency panels) does not apply to WIP. Avoid asserting state-specific requirements that equate WIP labels with finished product labels. Add quantity/weight/volume and UID explicitly, note METRC/seed-to-sale linkage where applicable, and remove truncated/erroneous jurisdiction claims and artifacts.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "sop",
        "standard",
        "record",
        "log",
        "lab",
        "potency"
      ],
      "expectedAnswer": "**Generating compliance summary** I need to summarize key points regarding labeling intermediary oils before refinement. This involves critical regulatory details and state-specific requirements, particularly in the cannabis industry. General regulations typically mandate lot identification and labeling of work-in-progress materials, requiring containers to be labeled with unique identifiers, product details, production dates, and risks. Final retail labeling rules don't apply to work-in-progress, but internal process labels are essential for traceability and chain-of-custody during storage and transfer.**Summarizing compliance requirements** I need to create a summary regarding whether intermediary oils require labeling before refinement. The main conclusion involves that general cannabis regulations often require lot/batch identification for work-in-progress materials, especially concerning traceability in the supply chain. Requirements typically include using a container with UID/lot/batch ID, product description, weight/volume, production date, and licensee information. While final retail labeling doesn't apply to WIP, internal process labels are essential for tracking and storage within licensed premises."
    },
    {
      "questionNum": 31,
      "question": "Can I repackage bulk oil into smaller units without creating a new UID?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In virtually every regulated market you **must create a new UID (or tag) for each smaller package** that results from repackaging bulk oil. The original bulk‑container UID stays on record, but the new units each need their own identifier so the seed‑to‑sale system can track them independently.\n\n---\n\n## Why a new UID is required\n\n| Reason | What it means for repackaging |\n|--------|-------------------------------|\n| **Traceability** | Regulators must be able to follow every gram from cultivation to the consumer. A new UID lets the state see exactly when, where, and how the bulk oil was split. |\n| **Inventory integrity** | The seed‑to‑sale software (e.g., METRC, BioTrackTHC, Leaf Data) treats each UID as a discrete inventory record. Without a new UID the system would think the bulk container still holds the original quantity. |\n| **Recall & safety** | If a problem is found in one of the smaller bottles, the UID points directly to the affected lot, not to the entire bulk batch. |\n| **Compliance reporting** | Most state rules (CA, CO, WA, MA, MI, etc.) explicitly state that “any repackaged product must receive a new tag/UID.” |\n\n---\n\n## How to do it correctly (general workflow)\n\n1. **Log into your state‑approved tracking system** (METRC, BioTrackTHC, etc.).  \n2. **Select “Repackage” or “Create Package”** and choose the bulk oil container as the **source**.  \n3. **Enter the new package details** (volume, product type, brand, etc.).  \n4. **Generate a new UID/tag for each smaller unit**. The system will automatically link the new UID(s) to the parent bulk UID, preserving the chain of custody.  \n5. **Print and affix the new tag** to each smaller bottle.  \n6. **Retain the original bulk UID** on the bulk container (or mark it “used”) so auditors can see the transformation.  \n7. **Record the transaction** (date, time, employee, location) – this is required for any future audit or recall.\n\n> **Tip:** In METRC you can “split” a package. The software will create a *parent‑child* relationship automatically, so you don’t have to manually note the original UID on each child package—just keep the bulk container in the system as “used” or “disposed.”\n\n---\n\n## State‑by‑State snapshot (most common markets)\n\n| State | Rule on repackaging bulk oil | UID requirement |\n|-------|-----------------------------|-----------------|\n| **California** | “All repackaged cannabis products must be assigned a new tag.” | New UID for each child package; parent UID remains in the system. |\n| **Colorado** | “Repackaging requires a new tag; the original tag stays on the source package.” | New UID per unit; link recorded in METRC. |\n| **Washington** | “Every package that is moved, split, or repackaged must receive a new label.” | New UID per unit; parent‑child relationship required. |\n| **Massachusetts** | “Repackaging triggers a new tag\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1166 (166?1000) | Cost: $0.000000*",
      "duration": 12174,
      "grade": "B",
      "score": 82,
      "grading": {
        "accuracy": 25,
        "completeness": 18,
        "relevance": 19,
        "clarity_structure": 12,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly answers that new UIDs are required for each smaller package",
        "Explains rationale (traceability, inventory integrity, recalls) accurately",
        "Provides a practical step-by-step workflow and mentions METRC split/parent-child linkage",
        "Directly addresses the repackaging scenario and inventory linkage to parent UID"
      ],
      "weaknesses": [
        "Does not mention carrying forward QA/COA testing status to the new packages",
        "Does not explicitly state labeling must include the new final package UID or that original UIDs cannot be reused",
        "No discussion of potential special cases (e.g., same package/lot handling nuances)",
        "State-by-state quotes appear generalized and the section is truncated, risking inaccuracy/clarity issues"
      ],
      "feedback": "Good, actionable guidance that correctly states new UIDs are needed and outlines the process. To reach gold-standard completeness, add notes on carrying over QA/COA status, confirm labeling must include the final package UID, explicitly state not to reuse the original UID, and avoid or qualify state-specific quotes. Address any edge cases or exceptions if applicable.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "inventory",
        "repackaging",
        "tracking",
        "metrc",
        "seed-to-sale"
      ],
      "expectedAnswer": "**Considering packaging and UIDs** Repackaging oil into smaller units probably means I need new UIDs for each new package. I also have to adjust inventory and maintain the chain of custody, ensuring that the QA testing status is carried over. The labeling will need to include the UID of the final package, and I shouldn't reuse the same UID. However, I wonder if there's a special case for when it's the same package? That might complicate things!**Considering repackaging requirements** Repackaging oil into smaller units probably means I need new UIDs for each package. I must adjust the inventory and ensure the chain of custody is maintained. It's crucial to carry over the QA testing status, and the labeling must include the UID of the final package without reusing the same UID. Wait, I wonder if there's a special case if it’s the same package? I'll need to clarify that!"
    },
    {
      "questionNum": 32,
      "question": "Is it compliant to pre-fill vape cartridges before the lab test results are back?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most regulated cannabis markets you should **not** release (fill) vape cartridges for sale or distribution until the batch’s laboratory results (COA) have been reviewed and approved. Doing so is typically considered a violation of “batch‑release” or “product‑release” requirements.\n\n---\n\n## Why pre‑filling before the COA is risky (and usually non‑compliant)\n\n| Regulatory Reason | What it means for your operation |\n|--------------------|-----------------------------------|\n| **Batch‑Release/Quality‑Control (QC) requirements** | State or provincial cannabis boards (e.g., California BSC, Massachusetts Cannabis Control Commission, Ontario CannaReg) require that every batch of product have a **signed release** based on lab data before it can be marketed. |\n| **Good Manufacturing Practices (GMP) / Good Production Practices (GPP)** | GMP‑style SOPs call for “quarantine” of finished product until final test results are verified. Filling cartridges is a “final‑step” that must occur after release. |\n| **Consumer safety** | Lab tests confirm potency, pesticide limits, residual solvents, heavy metals, microbial load, and terpene profile. Without that data you cannot guarantee the cartridge meets safety thresholds. |\n| **Labeling & potency accuracy** | THC/CBD percentages on the label must be derived from the COA. Pre‑filling before the COA can lead to mis‑labeling, which is a separate compliance violation. |\n| **Record‑keeping & traceability** | Most jurisdictions require a “batch record” that links the COA to the specific lot of cartridges. Filling before the COA makes that linkage ambiguous. |\n| **Legal liability** | If a non‑conforming product reaches the market, the manufacturer can face fines, product recalls, or loss of license. |\n\n---\n\n## Typical compliance workflow (illustrative)\n\n1. **Manufacture & extraction** → produce a **raw bulk** (oil, distillate, isolate).  \n2. **Quarantine** the bulk material; assign a batch/lot number.  \n3. **Submit the bulk** to an accredited cannabis testing lab.  \n4. **Receive COA** (potency, contaminants, residual solvents, etc.).  \n5. **QC review** – internal QA signs off that the batch meets all specs.  \n6. **Release** – the batch is marked “released for filling.”  \n7. **Fill cartridges** using the released bulk; record cartridge lot numbers that reference the released batch.  \n8. **Final packaging & labeling** – label reflects the COA data.  \n\nOnly after step 5 (release) should step 6 (filling) occur.\n\n---\n\n## Possible Exceptions (and why they’re still limited)\n\n| Situation | What you need to have in place |\n|-----------|-------------------------------|\n| **In‑house validated testing** (e.g., a state‑approved lab on‑site) | The lab must be accredited, the method validated, and the results must be formally documented before any product can be released. |\n| **“Hold‑for‑future‑fill”** (bulk stored under quarantine) | You may store the bulk but **cannot** fill cartridges for sale until the COA is approved. The filled cartridges can be kept in quarantine, but they must still be labeled as “awaiting release.” |\n| **Regulatory allowance for “pre‑fill” in emergency situations** | Very rare; would require explicit written permission from the regulatory authority and a documented risk‑mitigation plan. |\n\nIf any of these apply, you must still follow the regulator’s SOPs and retain full documentation.\n\n---\n\n## Practical Steps to Stay Compliant\n\n1. **Implement a “Quarantine” status** in your inventory system for any bulk material awaiting lab results.  \n2. **Create a SOP** that blocks the “fill” operation until the batch status is “Released.” Most ERP/LIMS systems can enforce this automatically.  \n3. **Maintain traceability**: each cartridge lot number must reference the raw‑material batch number and the associated COA.  \n4. **Label interim storage**: if you must store pre‑filled cartridges (e.g., for a short‑term hold), label them clearly as “Not for sale – pending lab release.”  \n5. **Stay current on jurisdiction‑specific rules**: each state/province may have subtle differences (e.g., some require a “final product test” in addition to bulk testing).  \n6. **Consult your regulator or a compliance attorney** before adopting any workflow that deviates from the standard release‑after‑testing model.\n\n---\n\n## Bottom line\n\n- **Do not fill and release vape cartridges until the batch’s lab results have been reviewed, approved, and documented.**  \n- Use a quarantine/hold process for any material awaiting COA.  \n- Keep thorough records linking COA data to the specific cartridge lot.  \n\nFollowing this workflow protects consumer safety, ensures label accuracy, and keeps your license in good standing. If you need a template SOP or assistance building a compliance‑trackable workflow, let me know!\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1404 (210?1194) | Cost: $0.000000*",
      "duration": 17680,
      "grade": "F",
      "score": 49,
      "grading": {
        "accuracy": 12,
        "completeness": 8,
        "relevance": 12,
        "clarity_structure": 11,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Emphasizes not releasing product for sale before COA approval",
        "Provides a general quarantine and QA/QC workflow",
        "Offers actionable steps on SOPs and traceability"
      ],
      "weaknesses": [
        "Not tailored to New York OCM requirements or 9 NYCRR Parts 128/130 as expected",
        "Incorrect or vague regulator references (e.g., California DCC misnamed, Ontario regulator mischaracterized)",
        "Core guidance suggests not filling before COA, which conflicts with jurisdictions (including NY) that require finished product (post-fill) testing",
        "Internal inconsistency about whether pre-filled cartridges can be held in quarantine prior to COA",
        "Omits NY-specific inventory tracking/repackaging rules and final product sampling requirements"
      ],
      "feedback": "The answer gives a solid general warning about not releasing products before COA and includes practical QC steps, but it fails to address New York-specific OCM rules and citations (9 NYCRR Parts 128 and 130) requested in the expected answer. It also inaccurately implies that filling should occur only after COA, which conflicts with jurisdictions that require final product testing (including filled cartridges). To improve, anchor the guidance to NY regulations, clarify that pre-filling is permissible if the lot remains quarantined and sampled as finished product, cite the relevant NY rules, and detail NY inventory tracking and labeling linkages to the COA.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "required",
        "must",
        "state",
        "oregon",
        "standard",
        "document",
        "record",
        "testing",
        "test",
        "coa",
        "certificate",
        "analysis",
        "lab",
        "potency"
      ],
      "expectedAnswer": "**Summarizing compliance for vape cartridges** I need to create a concise summary about whether it's compliant to pre-fill vape cartridges in New York before lab test results are back. It’s essential to include compliance details, inventory tracking, and main regulations for adult-use cannabis set by the Office of Cannabis Management (OCM). I'll focus on requirements for manufacturers, addressing testing protocols that need to be followed before sale, including final product sampling. Knowing the specific requirements for inhalable extracts and vape products is crucial here.**Recalling NY cannabis regulations** I need to recall specific parts of New York regulations, particularly the NY 9 NYCRR. There’s Part 130 on Packaging and Labeling, Part 128 covering Laboratory Testing, and I think there’s also Part 123 for Manufacturing and maybe Part 125? It’s important to keep these regulatory sections in mind when discussing compliance for adult-use cannabis in New York. I should focus especially on Part 130, which addresses Packaging, Labeling, and Marketing.**Assessing vape cartridge compliance** I need to create a summary on whether it's compliant to pre-fill vape cartridges before lab test results come back in New York. I’ll explore compliance details, including inventory tracking and repackaging. I'll summarize essential requirements and critical regulatory information, particularly focusing on New York's cannabis regulations from the Office of Cannabis Management. Typically, p..."
    },
    {
      "questionNum": 33,
      "question": "Do I have to update the batch weight in the system if I lose some product to spillage?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes – any loss (spillage, waste, breakage, etc.) must be reflected in the batch record and the overall inventory balance.\n\n---\n\n### Why you need to update the batch weight\n\n| Reason | What it means for you |\n|--------|-----------------------|\n| **Regulatory compliance** | State‑mandated seed‑to‑sale systems require that the *actual* weight of each batch be traceable at every step. Unrecorded loss creates a discrepancy that can trigger a compliance audit or a violation notice. |\n| **Accurate inventory & costing** | The system’s on‑hand inventory, cost of goods sold (COGS), and forecasting all rely on the recorded batch weight. Leaving the loss out will over‑state available product and distort margins. |\n| **Traceability & recall readiness** | If a batch ever needs to be recalled, the exact amount that left the facility must be known. Spillage that isn’t logged can break the chain‑of‑custody. |\n| **Internal controls & SOP adherence** | Most SOPs require a “Waste/Spillage” entry for each incident. Updating the batch weight is the formal way to close that loop. |\n\n---\n\n### How to record spillage in most seed‑to‑sale platforms (e.g., Metrc, BioTrackTHC, MJ Freeway)\n\n1. **Create a “Waste/Spillage” transaction**  \n   - Choose the appropriate waste code (e.g., *Spillage – Unrecoverable*).  \n   - Enter the **actual weight lost** (e.g., 0.25 lb).  \n\n2. **Link the transaction to the original batch**  \n   - Most systems will automatically deduct the loss from the batch’s remaining weight.  \n   - Verify that the batch’s “Remaining” weight reflects the reduction.\n\n3. **Attach supporting documentation** (optional but recommended)  \n   - Photo of the spill, incident report, or a signed waste log.  \n\n4. **Update inventory totals**  \n   - The system will recalc the facility’s total on‑hand weight.  \n   - Review the new totals to ensure they reconcile with physical counts.\n\n5. **Notify relevant personnel**  \n   - QA/Compliance manager  \n   - Production supervisor  \n   - Accounting (for COGS adjustments)\n\n---\n\n### Quick checklist for a spillage event\n\n- [ ] **Stop the process** (if safe to do so) and contain the spill.  \n- [ ] **Document** the incident (time, location, cause, weight).  \n- [ ] **Enter a waste/spillage record** in the seed‑to‑sale system.  \n- [ ] **Confirm the batch weight** has been reduced accordingly.  \n- [ ] **Re‑weigh the remaining product** (if required by your SOP).  \n- [ ] **File the incident report** for audit trails.\n\n---\n\n### Bottom line\n\n- **Do it.** Updating the batch weight (via a waste/spillage transaction) keeps you compliant, maintains accurate inventory, and protects you in the event of a recall or audit.  \n- **Don’t skip it.** Unrecorded losses lead to inventory mismatches, potential fines, and loss of credibility with regulators.\n\nIf you need step‑by‑step guidance for a specific platform (e.g., Metrc, BioTrackTHC) or help drafting a spillage SOP, just let me know and I can route you to the appropriate specialist.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1142 (172?970) | Cost: $0.000000*",
      "duration": 7469,
      "grade": "C",
      "score": 78,
      "grading": {
        "accuracy": 23,
        "completeness": 13,
        "relevance": 19,
        "clarity_structure": 14,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question with a clear yes",
        "Provides actionable steps for recording spillage in seed-to-sale systems",
        "Well-structured with reasons, process, and a checklist",
        "Emphasizes compliance and audit trail needs"
      ],
      "weaknesses": [
        "Lacks New York–specific compliance details expected (OCM rules, 9 NYCRR references)",
        "Does not mention NY’s mandated use of BioTrack for adult-use and daily reconciliation",
        "Omits the five-year record retention requirement",
        "References multiple platforms (e.g., Metrc) without clarifying NY system of record"
      ],
      "feedback": "Good general guidance and clear, actionable steps. To meet the expected standard, add New York–specific compliance details: cite OCM rules (9 NYCRR Parts 120–134), note that NY requires BioTrack for adult-use, inventory must be reconciled daily, all adjustments including spillage must be recorded, and records retained for five years. Include brief, BioTrack-specific steps and terminology.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "required",
        "state",
        "metrc",
        "sop",
        "standard",
        "documentation",
        "document",
        "record",
        "log",
        "potency",
        "batch",
        "thc",
        "date"
      ],
      "expectedAnswer": "**Researching cannabis compliance** I need to create a concise summary focusing on the cannabis industry compliance in New York regarding updating batch weight due to spillage. I should familiarize myself with NY regulations on inventory adjustments and waste. Notably, New York uses BioTrack for adult-use seed-to-sale tracking since 2023, and licensees must reconcile inventory daily and record any adjustments, including spillage and waste, maintaining records for five years. I should review OCM regulations and relevant parts to clarify.**Summarizing cannabis compliance** I need to create a concise summary for a cannabis compliance question in New York about updating batch weight in relation to product loss from spillage. It's essential to know NY regulations concerning inventory adjustments, including waste and destruction, particularly related to METRC and BioTrack. As of 2023, New York's OCM mandates using BioTrack for both medical and adult-use products. Licensees must reconcile inventory daily, record adjustments, and retain records for five years, in line with regulations in 9 NYCRR Parts 120-134."
    },
    {
      "questionNum": 34,
      "question": "Do I need to generate a new COA if I repackage the same batch in a different container?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most regulated markets you do **not** have to order a brand‑new, full‑panel COA for a simple repackaging, but you do need to document the change and, in many jurisdictions, issue a supplemental “re‑packaging” statement that ties the new container to the original COA.\n\n---\n\n## Why the original COA is still the “master” document\n| Reason | Explanation |\n|--------|-------------|\n| **Chemical composition unchanged** | The COA validates the cannabinoid/terpene profile, potency, contaminants, etc. If the product itself (oil, flower, isolate, etc.) is not altered, those results remain valid. |\n| **Batch integrity** | As long as you keep the same batch/lot number and maintain a closed‑loop chain‑of‑custody, the original analytical data continue to apply. |\n| **Regulatory focus** | Most regulators care about **what** is in the product, not the cosmetic container, provided the container does not introduce new hazards. |\n\n---\n\n## When a new COA *is* required\n1. **Material interaction risk** – If the new container is made of a material that could leach chemicals (e.g., certain plastics, metals, or adhesives) or absorb cannabinoids/terpenes, you must run at least a **migration/compatibility test** and attach those results to the COA.  \n2. **Significant label changes** – Adding new warnings, dosage instructions, or altering potency claims may trigger a “label amendment” review, which many agencies treat as a new product submission.  \n3. **Shelf‑life extension or reduction** – If the new packaging changes the product’s stability profile (e.g., better UV protection, different headspace oxygen), you need stability data to support the revised “use‑by” date.  \n4. **Regulatory jurisdiction** – Some states/countries (e.g., Colorado, Canada, the EU) explicitly require a **re‑certification** whenever the primary container is changed, even if inert. Check the local cannabis‑specific regulations.  \n\n---\n\n## Best‑Practice Workflow for Repackaging\n\n1. **Maintain Batch Documentation**  \n   - Keep the original COA on file and reference the same batch/lot number on the new container.  \n\n2. **Create a “Re‑Packaging Certificate” (RPC)**  \n   - **Header**: “Supplemental Certificate of Analysis – Re‑Packaging”  \n   - **Batch/Lot No.**: Same as original.  \n   - **Original COA Reference**: Include COA number, date, and lab.  \n   - **New Container Details**: Material, manufacturer, lot/serial number, dimensions, closure type.  \n   - **Compatibility Statement**: Summarize any migration or stability testing performed (or state “No material interaction expected per ASTM D-4169 & FDA guidance”).  \n   - **Signature**: QA/Regulatory officer and, if required, a third‑party lab sign‑off.  \n\n3. **Perform Minimal Testing (if needed)**  \n   - **Migration/Leach test** – Small‑scale (e.g., 10 g product in contact with container for 30 days, analyzed for metals, BPA, phthalates, etc.).  \n   - **Stability check** – Compare potency after 1 week in the new container vs. original; if within ±5 % you can generally rely on existing shelf‑life data.  \n\n4. **Update Labels & Records**  \n   - Ensure the new label carries the original batch number, potency, and any required container‑specific warnings (e.g., “Store in a cool, dark place”).  \n   - Log the repackaging event in your LIMS/ERP with timestamps, operator names, and QC sign‑offs.  \n\n5. **Communicate to Regulators (if required)**  \n   - Some jurisdictions\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1214 (214?1000) | Cost: $0.000000*",
      "duration": 7059,
      "grade": "D",
      "score": 64,
      "grading": {
        "accuracy": 19,
        "completeness": 11,
        "relevance": 15,
        "clarity_structure": 13,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly addresses whether a new COA is generally required for repackaging",
        "Well-structured with clear reasoning and a practical workflow",
        "Highlights documentation, chain-of-custody, and record-keeping best practices"
      ],
      "weaknesses": [
        "Misses key point that finished product testing may be required when product is infused/modified or when net weight changes, which can trigger potency/homogeneity verification at the package level",
        "Overemphasizes migration/compatibility and stability testing which are not typically COA requirements in many cannabis jurisdictions",
        "Potentially overgeneralizes jurisdictional rules (e.g., citing Colorado/Canada/EU) without precision and may be misleading",
        "Does not explicitly connect repackaging to unit-level potency/homogeneity verification needs"
      ],
      "feedback": "Your answer is clear, actionable, and generally correct that a simple container change usually does not require a new full COA. However, it omits critical regulatory triggers noted in the expected answer: repackaging of infused/modified products and changes to net weight can require finished product potency/homogeneity verification at the package level. Refocus on those scenarios and be cautious about prescribing migration/stability testing as COA requirements. Tighten jurisdictional claims or qualify them more precisely.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "required",
        "state",
        "epa",
        "standard",
        "documentation",
        "document",
        "record",
        "testing",
        "test",
        "coa",
        "certificate",
        "analysis",
        "lab"
      ],
      "expectedAnswer": "**Considering product re-packaging** Re-packaging can be a bit complex because it might require testing the finished product, especially if it's infused or modified. I need to think about whether changing the net weight could trigger a need for homogeneity or potency verification at the package level. It's important to ensure compliance and that everything is properly assessed in these scenarios. Let's make sure to cover all bases when it comes to re-packaging!**Considering product re-packaging** When re-packaging, it's important to think about whether we need to conduct a finished product test. This is especially true if the product has been infused or modified, or if the changes affect the net weight unit. Those aspects might require verifying homogeneity or potency at the package level. It sounds like a crucial step to ensure we meet quality and regulatory standards effectively!"
    },
    {
      "questionNum": 35,
      "question": "Can I submit test results to regulators before final packaging is complete?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most jurisdictions you can share analytical test results with regulators before the product is fully packaged, but the exact timing, format, and what else must accompany the data depend on the specific regulator (e.g., state cannabis board, FDA‑USDA, Health Canada, etc.) and the stage of your submission (pre‑market notification, license renewal, product‑change request, etc.).  \n\nBelow is a quick roadmap you can follow, plus the most regulatory nuances for cannabis‑derived products in the United States and Canada.\n\n---\n\n## 1. Why regulators often allow “early” test‑result submissions  \n\n| Reason | What it looks like in practice |\n|--------|--------------------------------|\n| **Safety verification** – regulators need to confirm that a new batch meets potency, contaminants, and pesticide limits before it reaches consumers. | You may be asked to upload a **Certificate of Analysis (CoA)** or a full **Laboratory Report** as part of a pre‑market notification (e.g., a “Product Notification” in Washington, “Form 10‑C” in Oregon). |\n| **Change‑control** – if you are modifying a formulation, packaging, or manufacturing process, the agency may request a **Product Change Request (PCR)** that includes test data before the change is approved. | The PCR typically contains the new analytical data *plus* a statement that the packaging change does not affect safety/quality. |\n| **License or renewal** – many state cannabis boards require a “lab results” file each reporting period, regardless of packaging status. | You submit the results on a quarterly/annual schedule; the packaging can be “in‑process” as long as the batch is traceable. |\n\n---\n\n## 2. General steps to submit test results **before** final packaging\n\n1. **Confirm the submission window & required documents**  \n   - Locate the regulator’s guidance (e.g., *Washington State Liquor and Cannabis Board – Lab Results Submission Guide*).  \n   - Identify the exact form(s) or portal upload fields (often a PDF upload and a data‑entry spreadsheet).  \n\n2. **Prepare a complete analytical package**  \n   - **Certificate of Analysis (CoA)** – includes batch/lot number, test dates, methods (e.g., USP <71> for microbiology, AOAC for pesticides).  \n   - **Full laboratory report** – raw data, instrument logs, LOD/LOQ, QA/QC metrics.  \n   - **Chain‑of‑Custody (CoC)** – proves the sample that was tested is the same one you will eventually package.  \n\n3. **Include a “Packaging Status” note**  \n   - State clearly that the sample is **pre‑final‑package** (e.g., “Bulk product, 5 L drum, awaiting final bottling”).  \n   - Provide a timeline for when the packaging will be completed and the product will be released.  \n\n4. **Submit through the official portal**  \n   - Most states have a **web portal** (e.g., *CannaReg* for Colorado, *Metrc* for several states).  \n   - Upload PDFs, fill required fields, and attach a brief **cover memo** summarizing: batch ID, test scope, results, and packaging status.  \n\n5. **Track the submission**  \n   - Keep the confirmation number.  \n   - If the regulator issues a “review pending” or “additional information required” notice, respond promptly with any missing packaging details.  \n\n---\n\n## 3. Common jurisdiction‑specific pointers  \n\n| Jurisdiction | Typical Requirement | Early‑submission allowance |\n|--------------|--------------------|----------------------------|\n| **California (Bureau of Cannabis Control)** | **Product Certification** (Form 4) + CoA. | Yes – you may upload the CoA before the product is sealed, but you must later submit a **Packaging Confirmation** (photo or label proof). |\n| **Colorado (CDFA)** | **Product Testing Report** uploaded to the *State Tracking System*. | Yes – batch test results are uploaded as soon as they are generated; the “Packaging Completed” flag can be set later. |\n| **Washington** | **Lab Results Form** (via the Liquor & Cannabis Board portal). | Yes – the board explicitly states that results can be submitted “while the product is still in bulk”. You must later attach a **Packaging Photo\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1164 (164?1000) | Cost: $0.000000*",
      "duration": 5899,
      "grade": "F",
      "score": 29,
      "grading": {
        "accuracy": 6,
        "completeness": 4,
        "relevance": 8,
        "clarity_structure": 8,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear structure and step-by-step framework",
        "Attempts to provide practical submission steps and documentation lists (CoA, CoC, portal use)"
      ],
      "weaknesses": [
        "Contradicts the expected jurisdictional guidance for New York where testing must be on the final packaged product",
        "Contains multiple factual errors about agencies and systems (e.g., California BCC now DCC; Colorado CDFA is incorrect; overstates regulator portal processes)",
        "Asserts broad allowance for pre-packaging submissions without citations and likely inaccurate (e.g., Washington ‘explicitly states’ claim)",
        "Omits New York-specific regulatory references (9 NYCRR Parts 130 and 132) and key requirements around final packaging and lot/batch linkage",
        "Truncated/incomplete content suggesting unfinished jurisdictional table",
        "Potentially misleading compliance advice that could cause noncompliance"
      ],
      "feedback": "The answer is well-structured but largely misaligned with the expected New York-specific requirement that testing occur on the final packaged product and that results be tied to specific lots/batches. It makes broad, questionable claims about early submissions across jurisdictions, includes agency inaccuracies, and lacks citations. Refocus on NY OCM regulations (9 NYCRR Parts 130 and 132), emphasize that submitting results before final packaging is typically not allowed, and note retesting requirements if repackaging occurs.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "inventory",
        "repackaging",
        "tracking",
        "metrc",
        "seed-to-sale",
        "packaging"
      ],
      "expectedAnswer": "**Synthesizing cannabis regulations** In New York, under the adult-use cannabis regulations for 2023/2024, testing must be conducted on the final product in its completed form and packaging. Test results are required to be associated with specific batches or lots, matching the product label with tested samples. While repackaging after testing may not be permitted unless products undergo retesting, many states require tests to occur after packaging or final formulation. Thus, submitting test results before final packaging is typically not allowed.**Reviewing New York cannabis regulations** I need to recall the specifics of 9 NYCRR Part 130, which covers the packaging and labeling for adult-use cannabis. It mandates that packaging must be child-resistant and tamper-evident to enhance safety. Additionally, I should keep in mind 9 NYCRR Part 132, which outlines testing requirements. These regulations are key to ensuring compliance within the cannabis industry and are important for maintaining quality and safety standards in New York.**Summarizing NY cannabis regulations** I need to summarize New York's cannabis regulations, particularly regarding test results and packaging. In New York for adult-use, testing must be conducted on the final product in its final form and packaging. The NY OCM regulations state that sampling must be from either a harvest or process lot, and test results should correspond to specific batches, ensuring labels match tested samples. Additionally, packagi..."
    },
    {
      "questionNum": 36,
      "question": "Am I allowed to digitally sign the waste disposal manifest, or do I need a physical copy?",
      "category": "recordkeeping-logs",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nIn most U.S. jurisdictions you can use a **digital/e‑signature** for a waste‑disposal manifest **if** the electronic system you use meets the applicable state and federal record‑keeping requirements. However, a few states (and some private haulers) still require a **paper copy** with a wet‑ink signature.  \n\nBelow is a quick decision‑tree and the key rules to watch, followed by next‑steps you can take.\n\n---  \n\n## 1. What kind of waste are we talking about?  \n\n| Waste type | Typical regulatory body | Digital‑signature status |\n|------------|------------------------|--------------------------|\n| **RCRA hazardous waste** (EPA‑regulated) | U.S. EPA – **e‑Manifest** system | **Allowed**. The EPA’s e‑Manifest platform (https://www.epa.gov/emergencies/e-manifest) accepts electronic signatures that meet 21 CFR Part 11. |\n| **Cannabis‑specific waste** (plant material, packaging, solvents) | State cannabis board / Department of Environmental Protection | Varies by state. Most states (e.g., CA, CO, MA, OR) **allow** e‑signatures **if** the system is audit‑ready and retains a tamper‑proof record. |\n| **Non‑hazardous municipal waste** | Local solid‑waste agency | Usually **allowed**, but check local ordinances. |\n| **Medical‑grade cannabis waste** (e.g., used PPE, sharps) | State health department | Often **requires** a paper copy, especially for sharps logs. |\n\n---\n\n## 2. Federal (EPA) Guidance – e‑Manifest\n\n* **Electronic signatures must**  \n  * Be uniquely linked to the signer (user‑ID, password, PKI certificate).  \n  * Be of signer’s identity and the integrity of the record.  \n  * Have an audit trail (date/time, IP address, version history).  \n\n* **‑keeping**  \n  * The electronic manifest must be retained for **at least three years** (or longer if state law says so).  \n  * Must be accessible for EPA inspection in its original electronic form.\n\nIf you’re using the EPA’s official e‑Manifest portal, the system already enforces these controls, so a digital signature is **fully compliant**.\n\n---\n\n## 3. State‑Specific Rules (Selected Examples)\n\n| State | Agency / Regulation | Digital‑signature allowance |\n|-------|---------------------|-----------------------------|\n| **California** | Department of Cannabis Control (DCC) – **B.5.5** | Allows e‑signatures if the software meets “electronic record‑keeping standards” (e.g., DocuSign with audit log). |\n| **Colorado** | Colorado Department of Revenue – **Reg. 23‑30** | Permits electronic signatures for the “Cannabis Waste Manifest” provided the system is **secure, immutable, and retains records for 5 years**. |\n| **Massachusetts** | Cannabis Control Commission – **Reg. 31‑30‑40** | Requires a *physical* signature **unless** the licensee has obtained a written waiver from the Commission. |\n| **Oregon** | Oregon Liquor & Cannabis Commission – **Reg. OAR 340‑001‑0010** | Accepts electronic signatures if the manifest is submitted via the state’s **online portal**. |\n| **Washington** | Washington State Department of Ecology – **RCW 70.120** | Allows e‑signatures for “hazardous waste manifests” if the system complies with **Title 70 RCW electronic record‑keeping**. |\n\n*If you are operating in a state not listed here, treat it the same way: locate the cannabis‑specific waste‑tracking regulation and look for language about “electronic signatures” or “digital records.”*\n\n---\n\n## 4. Practical Checklist for Using a Digital Signature\n\n1. **Choose a compliant e‑signature platform**  \n   * Must support **\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1170 (170?1000) | Cost: $0.000000*",
      "duration": 9855,
      "grade": "F",
      "score": 26,
      "grading": {
        "accuracy": 6,
        "completeness": 5,
        "relevance": 6,
        "clarity_structure": 6,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear high-level framing that e-signatures may be acceptable if system requirements are met",
        "Mentions EPA e-Manifest concept and need for audit trails",
        "Acknowledges variability by jurisdiction and hauler practices"
      ],
      "weaknesses": [
        "Fails to address New York-specific OCM/MRTA/9 NYCRR requirements requested by the question",
        "Includes multiple likely inaccurate or fabricated citations (e.g., 21 CFR Part 11 for EPA e-Manifest, several state regulation references)",
        "Potentially misleading federal guidance (EPA e-Manifest aligns with CROMERR, not 21 CFR Part 11)",
        "Content is truncated and leaves the checklist incomplete",
        "Over-generalized and omits cannabis-specific NY waste manifest rules and recordkeeping timelines"
      ],
      "feedback": "The answer is broadly structured but misses the core need: a New York-specific determination under OCM/MRTA and relevant 9 NYCRR parts. Several cited regulations appear inaccurate or irrelevant (e.g., 21 CFR Part 11 for EPA, questionable state cites), which undermines trust. Provide a direct NY-focused conclusion on whether digital signatures are permitted for cannabis waste manifests, cite the applicable OCM recordkeeping provisions, and clarify any requirements for electronic records (audit trail, retention, accessibility). Avoid speculative citations and complete the practical checklist with verifiable requirements.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "washington",
        "federal",
        "epa",
        "agency",
        "board",
        "sop"
      ],
      "expectedAnswer": "**Analyzing digital signatures for cannabis waste disposal** I'm looking to summarize regulations around whether a digital signature is allowed for waste disposal manifests in New York cannabis law. I need to consider the specific guidelines from the Office of Cannabis Management (OCM) and the MRTA. Typically, many states allow electronic signatures if there are security measures and audit trails. I should verify what the NY regulations specifically require regarding digital versus physical documentation in the context of waste management and recordkeeping.**Clarifying New York cannabis regulations** I'm trying to clarify the specific regulations related to adult-use cannabis in New York. This includes examining Part 123 for adult-use processors, Part 125 for distribution, and possibly Part 130. I also need to consider recordkeeping requirements under 9 NYCRR Part 135. It's a bit confusing, and I’m not entirely sure about the details, but I want to ensure I provide accurate and relevant information regarding compliance for adult-use cannabis.**Evaluating cannabis regulations** I need to summarize the cannabis question about digital signatures on waste disposal manifests, specifically for New York regulations. The key focus is on whether digital signatures are accepted versus needing a physical copy. In New York, the Office of Cannabis Management oversees these regulations, including waste disposal manifests and electronic records. I’ll check if New York allows electronic sign..."
    },
    {
      "questionNum": 37,
      "question": "How long do I need to retain extraction logbooks for compliance?",
      "category": "recordkeeping-logs",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Retention period for extraction logbooks – quick guide**\n\n| Jurisdiction | Minimum retention period* | When the clock starts | Notes / typical requirements |\n|--------------|---------------------------|----------------------|------------------------------|\n| **California (B&C Reg. 2615)** | **3 years** | 1 day after the last entry for that batch | Must be kept on‑site or in a readily accessible off‑site location; electronic copies must be identical to paper. |\n| **Colorado (Reg. 13‑905)** | **3 years** | Date of the last entry (or date the batch is destroyed/ sold) | Must be for inspection by the Department of Revenue; electronic backups required. |\n| **Oregon (OR Reg 222‑020‑0240)** | **3 years** | End of the calendar year in which the record was created | Both paper and electronic records must be retained; “archival” storage is acceptable if it remains readable. |\n| **Washington (WSLCB Reg. 21‑001‑140)** | **3 years** | Date the record is finalized (e.g., batch closed) | Must be kept in a “secure, tamper‑evident” manner; electronic records must have audit trails. |\n| **Maine (MCR 5‑C‑1005‑100)** | **3 years** | Date of the last entry for that extraction | Records must be available for the Office of Cannabis Policy. |\n| **Massachusetts (310 CMR 7.09)** | **3 years** | Date the record is completed | Must be stored in a “readily accessible” location for inspection. |\n| **Michigan (MCL 333.3125)** | **5 years** | Date of the last entry (or batch disposition) | Both paper and electronic logs must be retained; the longer period reflects the state’s broader “record‑keeping” rule. |\n| **Illinois (210 ILCS 815/13‑5)** | **5 years** | Date the record is | Electronic records must be backed up and protected against alteration. |\n| **Canada (Health Canada C.08.007)** | **2 years** | End of the calendar year in which the record was created | Federal requirement applies to all licensed producers; provincial rules may be longer. |\n| **Other states** | **Typically 3 years** | Same as above | If a state listed, the default in most U.S. cannabis statutes is three unless a specific rule states otherwise. |\n\n\\*If a jurisdiction has both state‑level and local‑municipal rules, use the **longer** of the two periods.\n\n---\n\n### Why the “clock” usually starts at the **last entry**  \n\n- Extraction logs are “closed” when the batch is finished (e.g., product packaged, waste destroyed, or inventory moved).  \n- Once that final entry is made, the record is considered complete and the retention timer begins.  \n\n---\n\n### Best‑practice checklist for staying compliant  \n\n1. **Standardize log format** – Use the state‑approved template (paper, electronic, or both).  \n2. **Create immutable electronic copies** – PDF/A or blockchain‑based audit trails are increasingly accepted.  \n3. **Store backups off‑site** – Cloud storage (encrypted, SOC‑2/ISO‑27001 compliant) + a physical copy in a fire‑proof safe.  \n4. **Label with “Retention End Date”** – Makes it easy for audits and for eventual secure destruction.  \n5. **Implement a “record‑disposition policy”** – Automate alerts 30 days before the expiry date so you can destroy or archive per regulations.  \n6. **Train staff** – Ensure everyone knows when a batch is “closed” and that the log entry must be finalised promptly.  \n7. **Document the storage method** – Keep a\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1164 (164?1000) | Cost: $0.000000*",
      "duration": 11139,
      "grade": "F",
      "score": 19,
      "grading": {
        "accuracy": 3,
        "completeness": 2,
        "relevance": 3,
        "clarity_structure": 8,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Well-organized with a clear structure (table and bullet points)",
        "Explains when the retention period typically starts for logs",
        "Includes some general best-practice guidance"
      ],
      "weaknesses": [
        "Does not address New York requirements at all, which is the core of the expected answer",
        "Omits the key 5-year retention requirement and on-site first 2 years rule for NY",
        "Multiple citations appear inaccurate or unrelated, risking misinformation",
        "Overly broad multi-jurisdiction approach without the requested jurisdiction",
        "Checklist is truncated and incomplete"
      ],
      "feedback": "This answer misses the specific New York requirement the user needs. State clearly that New York OCM regulations (9 NYCRR) require extraction logs to be retained for five years, kept on-site for the first two years, and available to OCM upon request; after two years, they may be stored off-site. Avoid broad multi-state tables unless asked, and ensure all citations are accurate and relevant. Tighten the response and complete the checklist.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "new york",
        "massachusetts",
        "michigan",
        "illinois",
        "sop"
      ],
      "expectedAnswer": "**Summarizing cannabis recordkeeping** I need to summarize the required retention period for extraction logbooks for compliance in New York. According to the New York Office of Cannabis Management (OCM) regulations under 9 NYCRR, adult-use cannabis processors must retain extraction logs for five years. These records should be accessible to the OCM upon request. Also, they need to be stored on-site for the first two years and can then be moved off-site. It's essential to incorporate these specifics for compliance.**Researching compliance requirements** I need to produce a concise summary for the user asking about how long to retain extraction logbooks for compliance in New York. I should include specific regulations from the New York Office of Cannabis Management. It seems like the rule is to maintain these records for five years, similar to other states. Logbooks must be available to the OCM on request, stored on-site for the first two years, and then off-site after that.**Identifying recordkeeping specifics** I need to consider the specific records that must be maintained, such as batch production and control records, sanitation logs, pest control documentation, and equipment maintenance records. I'll also remember to include extraction logbooks in this list. It's crucial to have all these details organized and accessible to ensure compliance and effective management of operations. Let’s make sure I cover all necessary areas for maintaining proper records!"
    },
    {
      "questionNum": 38,
      "question": "Can I dispose of spent biomass without mixing it with non-consumable waste first?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most jurisdictions you **cannot** simply dump spent cannabis biomass on its own; it must first be rendered **non‑consumable** and then handled as regulated waste (often mixed with other non‑consumable waste or sent to a licensed disposal facility).\n\n---\n\n## Why the extra step is required\n\n| Reason | What it means for your biomass |\n|--------|--------------------------------|\n| **Regulatory classification** | Once a plant has been cultivated for consumption, the material is classified as *“cannabis waste”* (or “controlled waste”) and is subject to strict handling rules. |\n| **Public‑health & diversion concerns** | Unprocessed spent buds, trim, or roots could be re‑processed for illicit use. Mixing with other waste or rendering it non‑consumable helps prevent diversion. |\n| **Environmental compliance** | Many states treat cannabis waste as hazardous or “special waste,” requiring it to be disposed of in approved landfills, incinerators, or composting facilities that accept non‑consumable material. |\n| **Record‑keeping & tracking** | Regulations often demand a chain‑of‑custody log. Mixing with a larger waste stream simplifies transport documentation and ensures the waste is accounted for. |\n\n---\n\n## Typical regulatory pathways (U.S. examples)\n\n| State | Required treatment before disposal | Acceptable disposal methods |\n|-------|-----------------------------------|------------------------------|\n| **California** (BPC, B.O.S.S.) | Must be *rendered non‑consumable* (e.g., shredding, grinding, solvent extraction, or incineration) before it can be classified as “non‑consumable waste.” | Licensed waste hauler, municipal landfill, or permitted incinerator. |\n| **Colorado** (MCR) | Must be *rendered non‑consumable* and then placed in a *sealed, labeled container* before transport. | Licensed hazardous‑waste carrier, approved landfill, or approved composting operation (if certified). |\n| **Oregon** (MSC) | Must be *rendered non‑consumable* (e.g., grinding, mixing with inert material) and *segregated* from consumable product waste. | Certified waste‑to‑energy plant, landfill, or composting facility with a cannabis‑waste permit. |\n| **Canada** (Health Canada) | Must be *rendered non‑consumable* (e.g., incinerated, chemical neutralization) before disposal. | Licensed waste‑disposal contractor, municipal landfill, or provincially approved incinerator. |\n\n*If you’re outside the U.S., check the equivalent national or provincial regulations.*\n\n---\n\n## How to render spent biomass “non‑consumable”\n\n1. **Mechanical processing** – Shred, grind, or pulverize the material to a particle size that cannot be reconstituted into a consumable product.\n2. **Thermal treatment** – Low‑temperature incineration, steam sterilization, or drying at ≥ 150 °C for a prescribed time.\n3. **Chemical extraction** – Run the biomass through a solvent wash (e.g., ethanol) that removes residual cannabinoids and terpenes.\n4. **Mixing with inert material** – Blend the processed biomass with a non‑cannabis waste stream (e.g., wood chips, sawdust) in a ratio required by your state (often 1:1 or greater).\n5. **Documentation** – Record the method, date, quantity, and personnel involved; retain logs for inspection.\n\n---\n\n## Disposal options after rendering\n\n| Method | When it’s appropriate | Key considerations |\n|--------|----------------------|--------------------|\n| **Licensed waste hauler** | Most common; you hand over sealed containers to a contractor. | Verify the hauler’s cannabis‑waste endorsement; keep the bill of l\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1168 (168?1000) | Cost: $0.000000*",
      "duration": 7474,
      "grade": "F",
      "score": 50,
      "grading": {
        "accuracy": 15,
        "completeness": 9,
        "relevance": 12,
        "clarity_structure": 8,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly states the general principle that cannabis biomass typically must be rendered non-consumable before disposal",
        "Offers practical methods to render waste non-consumable (e.g., grinding, mixing, documentation)",
        "Highlights diversion prevention and record-keeping considerations"
      ],
      "weaknesses": [
        "Does not address New York-specific requirements or cite 9 NYCRR Parts 125 and 130 as expected",
        "Overly long and not the requested concise 100–200 word summary",
        "Contains questionable or potentially inaccurate claims (e.g., many states treating cannabis waste as hazardous, specific temperature requirements, unclear state regulation references)",
        "Truncated/incomplete section at the end, harming clarity",
        "Does not directly answer whether mixing is required versus other rendering methods in New York"
      ],
      "feedback": "Provide a concise 100–200 word summary focused on New York waste-management compliance for spent biomass. Directly answer whether mixing with non-consumable waste is required or whether rendering by grinding/other methods suffices. Cite and align with NY OCM rules, specifically 9 NYCRR Parts 125 and 130, and mention permissible options such as on-site grinding, composting, or licensed hauler disposal. Remove speculative or inaccurate claims (e.g., hazardous-waste classification, specific temperatures) and ensure the response is complete and jurisdiction-specific.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "federal",
        "epa",
        "board",
        "sop",
        "procedure",
        "standard",
        "operating",
        "document",
        "record"
      ],
      "expectedAnswer": "**Summarizing waste management compliance** I need to create a concise 100-200 word summary focusing on waste management compliance regarding the disposal of spent biomass, such as cannabis plant material after extraction. The main question is whether I can dispose of it without mixing it with non-consumable waste. In many states, cannabis waste has to be mixed at a specific ratio to be rendered unusable, but New York regulations may have different requirements. I believe I should look into 9 NYCRR Part 130 and Part 125 for clarity.**Summarizing waste management compliance** I need to create a concise grading summary of 100-200 words covering waste management compliance regarding spent biomass disposal, specifically cannabis plant material after extraction. The key question is whether I can dispose of this waste without mixing it with non-consumable waste first. Generally, many states require this mixing, but some allow composting or on-site grinding. For New York, I should look into the regulations under NY OCM, particularly 9 NYCRR Part 130 or 125 for disposal guidelines."
    },
    {
      "questionNum": 39,
      "question": "Is it okay to store cannabis waste in the same area as general lab trash temporarily?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nIn most U.S. jurisdictions you **cannot** mix cannabis waste with ordinary laboratory trash, even for a short‑term holding period, unless you are following a state‑approved, documented waste‑segregation plan that meets all security, labeling, and containment requirements.  \n\nBelow is a practical checklist you can use to determine whether a temporary “co‑storage” is permissible in your operation and how to do it correctly if it is allowed.\n\n---\n\n## 1. Why the rule exists  \n\n| Reason | What it means for your lab |\n|--------|----------------------------|\n| **Regulatory compliance** (state cannabis boards, EPA, OSHA) | Cannabis waste is a *controlled* waste stream. Mixing it with regular trash can be interpreted as “im,” which can trigger fines, license suspensions, or criminal charges. |\n| **Security & diversion risk** | Cannabis waste can still contain usable product, plant material, or solvent residues. Keeping it separate reduces the chance of theft or accidental reuse. |\n| **Environmental protection** | Some waste (e.g., solvent‑soaked pads) is hazardous and must be handled as hazardous waste, not municipal solid waste. |\n| **Traceability & record‑keeping** | Separate containers make it easier to log weight/volume, maintain chain‑of‑custody, and produce disposal manifests. |\n\n---\n\n## 2. Typical statutory requirements (most states)\n\n| Requirement | Typical wording (example) |\n|-------------|---------------------------|\n| **Segregation** | “All cannabis waste shall be stored in a locked, fire‑rated container separate from non‑cannabis.” |\n| **Labeling** | “Container must be clearly marked ‘CANNABIS WASTE – DO NOT DISPOSE WITH GENERAL TRASH.’” |\n| **Security** | “Containers must be kept in a restricted‑access area with 24‑hour video monitoring.” |\n|Time limit** | “Waste may be stored on‑site for no longer than 30 days (or as specified in the waste‑management plan).” |\n| **Documentation** | “Every addition or removal must be logged, including weight, date, and responsible employee.” |\n| **Disposal** | “All waste must be transferred a state‑licensed disposal vendor within the storage time limit.” |\n\n*If any of the above items are missing from your SOP, you should treat cannabis waste as a separate stream and **not** co‑store it with general trash.*\n\n---\n\n## . When “temporary co‑storage” might be allowed  \n\n1. **You have an approved Waste Management Plan (WMP)** that explicitly states:  \n   - The **exact container type** (e.g., sealed, fire‑rated, tamper‑evident).  \n   - The **maximum dwell time** (often 24‑48 hrs for “interim” storage).  \n   - **Location restrictions** (must be in a locked, restricted‑access room, not a general trash chute).2. **The waste is placed in a **secondary container** that meets all labeling and security criteria** (e.g., a sealed, locked bin inside a regular trash can). The outer trash can must be **empty of any other waste** and clearly marked as a **cannabis‑waste holding bin**.\n\n3. **You have documented the temporary storage event** in your waste log, with signatures and timestamps, and you can produce the record on request.\n\nIf any of those conditions are *not* met, the storage is **non‑compliant**.\n\n---\n\n## 4. Practical steps to stay compliant\n\n| Step | Action |\n|------|--------|\n| **1. Identify waste type** | Separate *plant material*, *solvent‑soaked material*, *bio‑hazard* (e.g., tissue) and *hazardous* waste. Each may have its own storage rules. |\n| **2. Use the right container** | - Fire‑rated, lockable bin for plant waste.<br>- EPA‑approved hazardous waste drum for solvent‑soaked pads.<br>- Bio‑hazard bag for tissue. |\n| **3. Label clearly** | Include: “CANNABIS WASTE – DO\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1168 (168?1000) | Cost: $0.000000*",
      "duration": 6841,
      "grade": "F",
      "score": 53,
      "grading": {
        "accuracy": 17,
        "completeness": 10,
        "relevance": 13,
        "clarity_structure": 7,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Emphasizes that cannabis waste generally should not be mixed with general trash",
        "Provides practical, actionable checklist items (segregation, labeling, security, documentation)",
        "Highlights diversion risk and traceability requirements",
        "Notes conditions under which temporary co-storage might be allowed with a documented plan"
      ],
      "weaknesses": [
        "Fails to address New York-specific requirements (OCM/MRTA) or cite 9 NYCRR Parts 125, 128, and 131 as expected",
        "Overgeneralizes state requirements (e.g., “fire-rated” containers, universal licensed disposal vendor) without jurisdictional specificity",
        "Contains formatting and truncation errors, including incomplete sentences and stray meta text",
        "Does not clearly state that NY generally requires separate storage and does not tie guidance to 2023–2025 NY regulations",
        "Lacks citations or explicit references to authoritative NY sources"
      ],
      "feedback": "The answer offers useful general guidance on segregation, security, and documentation for cannabis waste, but it does not meet the expected New York-specific standard. To improve, tie the response directly to NY OCM/MRTA rules and cite 9 NYCRR Title 9 Parts 125, 128, and 131, clearly stating that NY generally requires separate storage of cannabis waste. Avoid broad, potentially inaccurate generalizations (e.g., universally ‘fire-rated’ containers), and provide precise NY compliance criteria. Clean up formatting and complete the truncated sections.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "epa",
        "sop",
        "procedure",
        "standard",
        "operating",
        "documentation"
      ],
      "expectedAnswer": "**Summarizing cannabis waste compliance in NY** It's crucial to understand New York's cannabis waste regulations regarding temporary storage with general lab trash. As of 2023-2025, compliance agents must refer to New York Office of Cannabis Management (OCM) and MRTA regulations. Key points include Parts 125, 128, and 131 concerning licensee operations and waste management. Under 9 NYCRR Title 9, conditions dictate that cannabis waste should generally be stored separately to ensure compliance with safety and regulatory standards during operation.**Researching cannabis waste regulations** I need to summarize the compliance question regarding storing cannabis waste alongside general lab trash in New York. The key is to understand that as of 2023-2025, the NY OCM and MRTA regulations dictate that cannabis waste must be managed according to specific guidelines found in Parts 125, 128, and 131 of the regulations. There are requirements for waste disposal, and ensuring adherence to these rules is critical for compliance in the cannabis industry."
    },
    {
      "questionNum": 40,
      "question": "Do I need a secondary person to verify destruction of cannabis waste?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In almost every U.S. jurisdiction that regulates commercial cannabis, a *second person* (often called a “witness,” “verifier,” or “chain‑of‑custody observer”) is required to sign off on the destruction of cannabis waste. The exact wording, who can serve, and how the verification is recorded differ by state, but the principle consistent: you cannot destroy waste unilaterally without an independent attestation.\n\n---\n\n## 1. Why a secondary person is required\n| Reason | What it accomplishes |\n|--------|----------------------|\n| **Regulatory control** | Prevents diversion of waste back into the market. |\n| **Chain‑of‑custody** | Creates a documented trail from generation to destruction. |\n| **Accountability** | Gives the regulator a verifiable record that a qualified party oversaw the process. |\n| **Safety & environmental compliance** | Confirms that hazardous or bio‑hazardous waste is handled per EPA/OSHA rules. |\n\n---\n\n## 2. Typical state‑level requirements (examples)\n\n| State | Who can act as the secondary verifier? | How verification is documented |\n|-------|----------------------------------------|--------------------------------|\n| **California (BPD)** | Any “authorized employee” not directly involved in the waste’s creation, or an external licensed waste‑disposal contractor. | Signed **Destruction Log** (paper or electronic) with date, time, method (e.g., incineration, autoclave), waste weight, and both parties’ signatures. |\n| **Colorado (MSC)** | A “waste witness” who is not a primary cultivator/processor; can be a compliance officer, security staff, or third‑party contractor. | **Waste Manifest** plus a **Witness Attestation Form** (electronic signature accepted). |\n| **Oregon (ODF)** | A designated “waste manager” and a separate “witness” (often a security guard or auditor). | **Destruction Record** in the ODF’s online portal, requiring two distinct user IDs for the event. |\n| **Washington (LCA)** | A licensed “waste disposal contractor” must provide a **Certificate oftruction** signed by both the contractor and a facility representative. | Uploaded to the state’s compliance portal within 24 hrs. |\n| **Maine** | A “waste verifier” (any employee not involved in the waste generation) must co‑sign the **Waste Destruction Log**. | Physical log kept on‑site for 3 years; electronic copy optional. |\n\n*Key take‑away:* The verifier must be **independent of the waste‑generation activity**. Many states explicitly ban the same person who created the waste from also signing off on its destruction.\n\n---\n\n## 3. What “secondary person” verification looks like in practice\n\n1. **Pre‑Destruction Checklist**  \n   - Waste type (plant material, solvents, hazardous chemicals).  \n   - Quantity (weight or volume).  \n   - Storage location and segregation.\n\n2. **Witness Presence**  \n   - Both parties (operator & witness) stand by the waste at the moment of destruction (inciner, autoclave, shredding, etc.).  \n   - The witness may be required to observe the entire process, not just the start.\n\n3. **Documentation**  \n   - **Paper Log**: Date, time, method, waste description, weight, signatures, and any equipment ID (e.g., incinerator serial #).  \n   - **Electronic System**: Most states now accept a digital form with two separate user logins, timestamps, and optional photo/video attachment.  \n\n4. **Post‑Destruction**  \n   - Retain the signed log/manifest for the statutory retention period (usually 2‑3 years).  \n   - Upload a copy to the state’s compliance portal if required.  \n\n5. **Third‑Party Contractors**  \n   - If you hire a licensed waste‑disposal service, the contractor typically provides a **Certificate of Destruction** that includes\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1164 (164?1000) | Cost: $0.000000*",
      "duration": 7940,
      "grade": "F",
      "score": 46,
      "grading": {
        "accuracy": 10,
        "completeness": 8,
        "relevance": 12,
        "clarity_structure": 11,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, organized structure with step-by-step process",
        "Explains rationale for verification and chain-of-custody",
        "Provides a practical overview of documentation elements and retention concepts"
      ],
      "weaknesses": [
        "Does not address New York-specific rules or OCM requirements as implied by the category and expected answer",
        "Overgeneralizes by claiming almost every jurisdiction requires a secondary witness, which is not universally accurate",
        "Contains multiple incorrect or dubious state agency names and requirements (e.g., California, Colorado, Oregon, Washington acronyms/policies)",
        "Misses key recordkeeping details from the expected answer (e.g., reason for destruction, personnel specifics, secure storage of records)",
        "Omits the requirement to render cannabis waste unusable by mixing with non-cannabis material, a central compliance point",
        "Answer appears truncated and incomplete at the end"
      ],
      "feedback": "Refocus on New York OCM regulations and cite the relevant parts (e.g., 9 NYCRR Parts 130–134). Clearly state whether NY requires a second person to witness destruction and detail the requirement to render cannabis waste unusable by mixing with non-cannabis material. Include specific recordkeeping fields (date, time, method, amount, reason, personnel) and note retention and secure storage. Avoid overbroad statements about all jurisdictions and correct inaccurate agency references and examples. Provide precise, state-specific guidance rather than generic assertions.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "michigan",
        "illinois",
        "board"
      ],
      "expectedAnswer": "**Summarizing cannabis waste regulations** I'm focusing on summarizing the expected answer about whether a secondary person is needed to verify the destruction of cannabis waste in New York. I need to clarify the specific state regulations, particularly the Office of Cannabis Management rules, which could include Parts 130-134 for adult use and possibly Part 132 for operations. I'll remember that in many states, a witness and video are required for destruction. For New York's regulations, cannabis waste must be unusable and mixed with non-cannabis materials before disposal.**Detailing record-keeping requirements** I need to emphasize that specific records must be maintained regarding cannabis waste destruction, including the date, time, method, amount, reason, and personnel involved. It's crucial to ensure these records are stored securely and are not accessible to the public. This helps maintain compliance and accountability in waste management. I'll make sure the user understands the importance of these details for proper documentation. need to ensure that all records are kept properly, including the date, time, method, amount, reason, and personnel involved. It's crucial that these records are stored securely and are not accessible to the public. I think it’s essential to be diligent about maintaining this information to uphold any necessary standards or regulations. So, I need to focus on keeping things organized and safe!"
    }
  ],
  "status": "In Progress: 40/438 questions completed"
}